Synergistic mechanisms involved in the antidepressant effects of agomelatine (Englisch)
- Neue Suche nach: Tardito, D.
- Neue Suche nach: Molteni, R.
- Neue Suche nach: Popoli, M.
- Neue Suche nach: Racagni, G.
- Neue Suche nach: Tardito, D.
- Neue Suche nach: Molteni, R.
- Neue Suche nach: Popoli, M.
- Neue Suche nach: Racagni, G.
In:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
;
22
;
S482-S486
;
2012
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Synergistic mechanisms involved in the antidepressant effects of agomelatine
-
Beteiligte:Tardito, D. ( Autor:in ) / Molteni, R. ( Autor:in ) / Popoli, M. ( Autor:in ) / Racagni, G. ( Autor:in )
-
Erschienen in:EUROPEAN NEUROPSYCHOPHARMACOLOGY ; 22 ; S482-S486
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2012
-
Format / Umfang:S482-S486
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.8 / 615.1
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 22
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analysesArnone, D. / McIntosh, A. M. / Ebmeier, K. P. / Munafo, M. R. / Anderson, I. M. et al. | 2012
- 17
-
Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: Results from a 3-month prospective open-label studyWampers, M. / Hanssens, L. / van Winkel, R. / Heald, A. / Collette, J. / Peuskens, J. / Reginster, J. Y. / Scheen, A. / De Hert, M. et al. | 2012
- 27
-
CB1 receptor antagonism/inverse agonism increases motor system excitability in humansOliviero, A. / Arevalo-Martin, A. / Rotondi, M. / Garcia-Ovejero, D. / Mordillo-Mateos, L. / Lozano-Sicilia, A. / Panyavin, I. / Chiovato, L. / Aguilar, J. / Foffani, G. et al. | 2012
- 36
-
The socioeconomic consequences of multiple sclerosis: A controlled national studyJennum, P. / Wanscher, B. / Frederiksen, J. / Kjellberg, J. et al. | 2012
- 44
-
Trial Simulation to estimate Type I error when a population window enrichment strategy is used to improve efficiency of clinical trials in depressionGomeni, R. / Merlo-Pich, E. et al. | 2012
- 53
-
Methylphenidate administration determines enduring changes in neuroglial network in ratsCavaliere, C. / Cirillo, G. / Bianco, M. R. / Adriani, W. / De Simone, A. / Leo, D. / Perrone-Capano, C. / Papa, M. et al. | 2012
- 64
-
Abnormality of VTA local field potential in an animal model of depression was restored by patterned DBS treatmentFriedman, A. / Lax, E. / Abraham, L. / Tischler, H. / Yadid, G. et al. | 2012
- 72
-
Neutralization of endogenous digitalis-like compounds alters catecholamines metabolism in the brain and elicits anti-depressive behaviorGoldstein, I. / Lax, E. / Gispan-Herman, I. / Ovadia, H. / Rosen, H. / Yadid, G. / Lichtstein, D. et al. | 2012
- 81
-
Mechanisms of neuropathic painNickel, F. T. / Seifert, F. / Lanz, S. / Maihofner, C. et al. | 2012
- 92
-
Concomitant blockade of 5-HT1A receptor and 5-HT transporter: Use of the Hunter Serotonin Toxicity Criteria in a clinical pharmacology studyParks, V. / Philipp, A. W. / Raje, S. / Plotka, A. / Schechter, L. E. / Connell, J. / Chalon, S. et al. | 2012
- 100
-
Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: A voxel-based meta-analysis of functional magnetic resonance imaging studiesDelvecchio, G. / Fossati, P. / Boyer, P. / Brambilla, P. / Falkai, P. / Gruber, O. / Hietala, J. / Lawrie, S. M. / Martinot, J. L. / McIntosh, A. M. et al. | 2012
- 114
-
Substance use and regional gray matter volume in individuals at high risk of psychosisStone, J. M. / Bhattacharyya, S. / Barker, G. J. / McGuire, P. K. et al. | 2012
- 123
-
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: Long-term changes in weight and metabolic profilesKemp, D. E. / Karayal, O. N. / Calabrese, J. R. / Sachs, G. S. / Pappadopulos, E. / Ice, K. S. / Siu, C. O. / Vieta, E. et al. | 2012
- 132
-
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: An open preliminary studyFabrazzo, M. / Perris, F. / Monteleone, P. / Esposito, G. / Catapano, F. / Maj, M. et al. | 2012
- 137
-
Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?Baldwin, D. S. / Schweizer, E. / Xu, Y. / Lyndon, G. et al. | 2012
- 143
-
Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expressionLeri, F. / Zhou, Y. / Carmichael, B. / Cummins, E. / Kreek, M. J. et al. | 2012
- 153
-
Validation of the dimensionality emergence assay for the measurement of innate anxiety in laboratory miceJain, A. / Dvorkin, A. / Fonio, E. / Golani, I. / Gross, C. T. et al. | 2012
- 165
-
Clozapine resistance: Augmentation strategiesPorcelli, S. / Balzarro, B. / Serretti, A. et al. | 2012
- 183
-
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trialCO-MED, S. T. / Friedman, E. S. / Davis, L. L. / Zisook, S. / Wisniewski, S. R. / Trivedi, M. H. / Fava, M. / Rush, A. J. et al. | 2012
- 200
-
The effect of niacin on facial blood flow in people with an elevated fear of negative evaluationDrummond, P. D. / Lazaroo, D. et al. | 2012
- 205
-
The long-term abnormalities in circadian expression of Period 1 and Period 2 genes in response to stress is normalized by agomelatine administered immediately after exposureKoresh, O. / Kozlovsky, N. / Kaplan, Z. / Zohar, J. / Matar, M. A. / Cohen, H. et al. | 2012
- 222
-
fMRI fingerprint of unconditioned fear-like behavior in rats exposed to trimethylthiazolineKeszler, M. S. / Debilly, S. / Schoppenthau, S. / Bielser, T. / Bruns, A. / Kunnecke, B. / von Kienlin, M. / Wettstein, J. G. / Moreau, J. L. / Risterucci, C. et al. | 2012
- 231
-
Interaction of mephedrone with dopamine and serotonin targets in ratsMartinez-Clemente, J. / Escubedo, E. / Pubill, D. / Camarasa, J. et al. | 2012
- 237
-
Corrigendum to ''Cost of disorders of the brain in Europe 2010'' [Eur. Neuropsychopharmacol. 21 (2011) 718-779]on behalf, o. t. / Gustavsson, A. / Svensson, M. / Jacobi, F. / Allgulander, C. / Alonso, J. / Beghi, E. / Dodel, R. / Ekman, M. / Faravelli, C. et al. | 2012
- 239
-
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacyPorcelli, S. / Fabbri, C. / Serretti, A. et al. | 2012
- 259
-
The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder - A European Multicenter StudySchosser, A. / Calati, R. / Serretti, A. / Massat, I. / A. Kocabas, N. / Papageorgiou, K. / Linotte, S. / Mendlewicz, J. / Souery, D. / Zohar, J. et al. | 2012
- 267
-
Efficacy of a targeted cognitive-behavioral treatment program for cannabis use disorders (CANDIS*)Hoch, E. / Noack, R. / Henker, J. / Pixa, A. / Hofler, M. / Behrendt, S. / Buhringer, G. / Wittchen, H. U. et al. | 2012
- 281
-
The CC genotype of transforming growth factor-b1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depressionCaraci, F. / Bosco, P. / Signorelli, M. / Spada, R. S. / Cosentino, F. I. / Toscano, G. / Bonforte, C. / Muratore, S. / Prestianni, G. / Panerai, S. et al. | 2012
- 290
-
Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese ratsvan de Giessen, E. / de Bruin, K. / la Fleur, S. E. / van den Brink, W. / Booij, J. et al. | 2012
- 300
-
Prenatal exposure to bacterial endotoxin reduces the number of GAD67- and reelin-immunoreactive neurons in the hippocampus of rat offspringNouel, D. / Burt, M. / Zhang, Y. / Harvey, L. / Boksa, P. et al. | 2012
- 308
-
Evaluation of sigma () receptors in the antidepressant-like effects of ketamine in vitro and in vivoRobson, M. J. / Elliott, M. / Seminerio, M. J. / Matsumoto, R. R. et al. | 2012
- 319
-
New insights on the consequences of biotransformation processes on the distribution and pharmacodynamic profiles of some neuropsychotropic drugsVoicu, V. A. / de Leon, J. / Medvedovici, A. V. / Radulescu, F. S. / Miron, D. S. et al. | 2012
- 330
-
Neuropathological abnormalities of astrocytes, GABAergic neurons, and pyramidal neurons in the dorsolateral prefrontal cortices of patients with major depressive disorderOh, D. H. / Son, H. / Hwang, S. / Kim, S. H. et al. | 2012
- 339
-
Polarity index of pharmacological agents used for maintenance treatment of bipolar disorderPopovic, D. / Reinares, M. / Goikolea, J. M. / Bonnin, C. M. / Gonzalez-Pinto, A. / Vieta, E. et al. | 2012
- 347
-
Severe and anxious depression: Combining definitions of clinical sub-types to identify patients differentially responsive to selective serotonin reuptake inhibitorsPapakostas, G. I. / Fan, H. / Tedeschini, E. et al. | 2012
- 356
-
Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later lifedu Bois, T. M. / Newell, K. A. / Huang, X. F. et al. | 2012
- 364
-
Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levelsWeston-Green, K. / Huang, X. F. / Lian, J. / Deng, C. et al. | 2012
- 374
-
The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gatingFeifel, D. / Shilling, P. D. / Belcher, A. M. et al. | 2012
- 379
-
Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse modelGreenbaum, L. / Lifschytz, T. / Zozulinsky, P. / Broner, E. C. / Slonimsky, A. / Kohn, Y. / Lerer, B. et al. | 2012
- 387
-
Antipsychotic medication and prefrontal cortex activation: A review of neuroimaging findingsLiemburg, E. J. / Knegtering, H. / Klein, H. C. / Kortekaas, R. / Aleman, A. et al. | 2012
- 401
-
Hematological clozapine monitoring with a point-of-care device: A randomized cross-over trialNielsen, J. / Thode, D. / Stenager, E. / Andersen, K. O. / Sondrup, U. / Hansen, T. N. / Munk, A. M. / Lykkegaard, S. / Gosvig, A. / Petrov, I. et al. | 2012
- 406
-
Predictors of medium and long-term outcome following capsulotomy for obsessive-compulsive disorder: One site may not fit allRuck, C. / Larsson, K. J. / Mataix-Cols, D. et al. | 2012
- 415
-
Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatmentKelleher, J. P. / Centorrino, F. / Huxley, N. A. / Bates, J. A. / Drake, J. K. / Egli, S. / Baldessarini, R. J. et al. | 2012
- 419
-
Perinatal effects on in vivo measures of human brain serotonin synthesis in adulthood: A 27-year longitudinal studyBooij, L. / Benkelfat, C. / Leyton, M. / Vitaro, F. / Gravel, P. / Levesque, M. L. / Arseneault, L. / Diksic, M. / Tremblay, R. E. et al. | 2012
- 424
-
VEGF regulates antidepressant effects of lamotrigineSun, R. / Li, N. / Li, T. et al. | 2012
- 431
-
Effects of poloxamer 407-induced hyperlipidemia on the pharmacokinetics of carbamazepine and its 10,11-epoxide metabolite in rats: Impact of decreased expression of both CYP3A1/2 and microsomal epoxide hydrolaseLee, Y. S. / Kim, Y. W. / Kim, S. G. / Lee, I. / Lee, M. G. / Kang, H. E. et al. | 2012
- 441
-
Imaging trait anxiety in high anxiety F344 rats: Focus on the dorsomedial prefrontal cortexPrinssen, E. P. / Nicolas, L. B. / Klein, S. / Grundschober, C. / Lopez-Lopez, C. / Keszler, M. S. / Bruns, A. / von Kienlin, M. / Wettstein, J. G. / Moreau, J. L. et al. | 2012
- 453
-
European Group for the Study of Resistant Depression (GSRD) - Where have we gone so far: Review of clinical and genetic findingsSchosser, A. / Serretti, A. / Souery, D. / Mendlewicz, J. / Zohar, J. / Montgomery, S. / Kasper, S. et al. | 2012
- 469
-
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: A three-center double-blind placebo-controlled studyKoychev, I. / McMullen, K. / Lees, J. / Dadhiwala, R. / Grayson, L. / Perry, C. / Schmechtig, A. / Walters, J. / Craig, K. J. / Dawson, G. R. et al. | 2012
- 482
-
A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD)Baldwin, D. S. / Loft, H. / Dragheim, M. et al. | 2012
- 492
-
The acute effects of d-amphetamine and d-methamphetamine on ERP components in humansSilber, B. / Croft, R. / Camfield, D. A. / Downey, L. A. / Papafotiou, K. / Stough, C. et al. | 2012
- 501
-
Equipercentile linking of the Brief Psychiatric Rating Scale and the Clinical Global Impression Scale in a catchment areaLeucht, S. / Engel, R. R. / Davis, J. M. / Kissling, W. / Meyer zur Capellen, K. / Schmausz, M. / Messer, T. et al. | 2012
- 506
-
Early gene mapping after deep brain stimulation in a rat model of tardive dyskinesia: Comparison with transient local inactivationCreed, M. C. / Hamani, C. / Nobrega, J. N. et al. | 2012
- 518
-
Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brainGhanbari, R. / El Mansari, M. / Blier, P. et al. | 2012
- 527
-
Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptorde Bartolomeis, A. / Tomasetti, C. / Cicale, M. / Yuan, P. X. / Manji, H. K. et al. | 2012
- 537
-
Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRISchouw, M. L. / Gevers, S. / Caan, M. W. / Majoie, C. B. / Booij, J. / Nederveen, A. J. / Reneman, L. et al. | 2012
- 546
-
Physiological and affective reactivity to a 35% CO2 inhalation challenge in individuals differing in the 5-HTTLPR genotype and trait neuroticismVerschoor, E. / Markus, C. R. et al. | 2012
- 555
-
Differential effects of ADORA2A gene variations in pre-attentive visual sensory memory subprocessesBeste, C. / Stock, A. K. / Ness, V. / Epplen, J. T. / Arning, L. et al. | 2012
- 562
-
Age, sex and NK1 receptors in the human brain - A positron emission tomography study with [^1^1C]GR205171Engman, J. / Ahs, F. / Furmark, T. / Linnman, C. / Pissiota, A. / Appel, L. / Frans, O. / Langstrom, B. / Fredrikson, M. et al. | 2012
- 569
-
Changes in trend of antipsychotics prescription in patients treated with cholinesterase inhibitors after warnings from Italian Medicines Agency. Results from the EPIFARM-Elderly ProjectFranchi, C. / Tettamanti, M. / Marengoni, A. / Bonometti, F. / Pasina, L. / Cortesi, L. / Fortino, I. / Bortolotti, A. / Merlino, L. / Lucca, U. et al. | 2012
- 578
-
A link between oxytocin and serotonin in humans: Supporting evidence from peripheral markersMarazziti, D. / Baroni, S. / Giannaccini, G. / Betti, L. / Massimetti, G. / Carmassi, C. / Catena-Dell'Osso, M. et al. | 2012
- 584
-
Acutely applied MDMA enhances long-term potentiation in rat hippocampus involving D1/D5 and 5-HT2 receptors through a polysynaptic mechanismRozas, C. / Loyola, S. / Ugarte, G. / Zeise, M. L. / Reyes-Parada, M. / Pancetti, F. / Rojas, P. / Morales, B. et al. | 2012
- 596
-
Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatmentsYang, C. P. / Wang, H. A. / Tsai, T. H. / Fan, A. / Hsu, C. L. / Chen, C. J. / Hong, C. J. / Chen, Y. M. et al. | 2012
- 607
-
The melanin-concentrating hormone (MCH) system in an animal model of depression-like behaviorGarcia-Fuster, M. J. / Parks, G. S. / Clinton, S. M. / Watson, S. J. / Akil, H. / Civelli, O. et al. | 2012
- 615
-
Olfactory function and alternation learning in eating disordersStein, D. / Gross-Isseroff, R. / Besserglick, R. / Ziv, A. / Mayer, G. / Yaroslavsky, A. / Toledano, A. / Voet, H. / Weizman, A. / Hermesh, H. et al. | 2012
- 625
-
Clinical response to antipsychotic drug treatment: Association study of polymorphisms in six candidate genesGROUP, i. / Vehof, J. / Burger, H. / Wilffert, B. / Al Hadithy, A. / Alizadeh, B. Z. / Snieder, H. et al. | 2012
- 632
-
Polymorphisms in AKR1C4 and HSD3B2 and differences in serum DHEAS and progesterone are associated with paranoid ideation during mania or hypomania in bipolar disorderJohansson, A. G. / Nikamo, P. / Schalling, M. / Landen, M. et al. | 2012
- 641
-
Association between the dexamethasone suppression test and serotonin transporter availability in healthy volunteers - A SPECT with [^1^2^3I] ADAM studyTsai, H. Y. / Lee, I. H. / Yeh, T. L. / Yao, W. J. / Chen, K. C. / Chen, P. S. / Chiu, N. T. / Lu, R. B. / Yang, Y. K. et al. | 2012
- 647
-
The association between availability of serotonin transporters and time to relapse in heroin users - A two-isotope SPECT small sample pilot studyLin, S. H. / Chen, K. C. / Lee, S. Y. / Yao, W. J. / Chiu, N. T. / Lee, I. H. / Chen, P. S. / Yeh, T. L. / Liao, M. H. / Lu, R. B. et al. | 2012
- 651
-
The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stressChristensen, J. H. / Elfving, B. / Muller, H. K. / Fryland, T. / Nyegaard, M. / Corydon, T. J. / Nielsen, A. L. / Mors, O. / Wegener, G. / Borglum, A. D. et al. | 2012
- 657
-
Marked inbred mouse strain difference in the expression of quinpirole induced compulsive like behavior based on behavioral pattern analysisde Haas, R. / Seddik, A. / Oppelaar, H. / Westenberg, H. G. / Kas, M. J. et al. | 2012
- 664
-
Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathwayMcLaughlin, R. J. / Hill, M. N. / Bambico, F. R. / Stuhr, K. L. / Gobbi, G. / Hillard, C. J. / Gorzalka, B. B. et al. | 2012
- 672
-
Hippocampus-specific deletion of tissue plasminogen activator ''tPA'' in adult mice impairs depression- and anxiety-like behaviorsBahi, A. / Dreyer, J. L. et al. | 2012
- 683
-
Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: Exploration of drug targets through the Stanley Neuropathology Integrative DatabaseKim, S. / Zavitsanou, K. / Gurguis, G. / Webster, M. J. et al. | 2012
- 695
-
Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patientsWang, S. C. / Tsou, H. H. / Chen, C. H. / Chen, Y. T. / Ho, I. K. / Hsiao, C. F. / Chou, S. Y. / Lin, Y. F. / Fang, K. C. / Huang, C. L. et al. | 2012
- 704
-
Alcohol consumption and premotor corpus callosum in older adultsKapogiannis, D. / Kisser, J. / Davatzikos, C. / Ferrucci, L. / Metter, J. / Resnick, S. M. et al. | 2012
- 711
-
Does prior antidepressant treatment of major depression impact brain function during current treatment?Hunter, A. M. / Cook, I. A. / Leuchter, A. F. et al. | 2012
- 721
-
A double-blind, randomized, placebo-controlled study with JNJ-37822681, a novel, highly selective, fast dissociating D2 receptor antagonist in the treatment of acute exacerbation of schizophreniaSchmidt, M. E. / Kent, J. M. / Daly, E. / Janssens, L. / Van Osselaer, N. / Husken, G. / Anghelescu, I. G. / Van Nueten, L. et al. | 2012
- 734
-
Dexamphetamine reduces auditory P3 delta power and phase-locking while increasing gamma powerAlbrecht, M. A. / Price, G. / Lee, J. / Iyyalol, R. / Martin-Iverson, M. T. et al. | 2012
- 747
-
DAI-10 is as good as DAI-30 in schizophreniaNielsen, R. E. / Lindstrom, E. / Nielsen, J. / Levander, S. et al. | 2012
- 751
-
Synergistic antidepressant-like action of gaboxadol and escitalopramChristensen, T. / Betry, C. / Mnie-Filali, O. / Etievant, A. / Ebert, B. / Haddjeri, N. / Wiborg, O. et al. | 2012
- 761
-
Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904Banasikowski, T. J. / Beninger, R. J. et al. | 2012
- 769
-
EditorialGispen-de Wied, C. / de Andres-Trelles, F. et al. | 2012
- 770
-
Placebo, a historical perspectiveCzerniak, E. / Davidson, M. et al. | 2012
- 775
-
Those famous red pills—Deliberations and hesitations. Ethics of placebo use in therapeutic and research settingsTouwen, D. P. / Engberts, D. P. et al. | 2012
- 782
-
Psychiatry should not become hostage to placebo: An alternative interpretation of antidepressant–placebo differences in the treatment response in depressionRihmer, Z. / Dome, P. / Baldwin, D. S. / Gonda, X. et al. | 2012
- 787
-
Placebo effect in child and adolescent psychiatric trialsParellada, M. / Moreno, C. / Moreno, M. / Espliego, A. / de Portugal, E. / Arango, C. et al. | 2012
- 800
-
Head to head comparisons as an alternative to placebo-controlled trialsVieta, E. / Cruz, N. et al. | 2012
- 804
-
The placebo arm in clinical studies for treatment of Psychiatric Disorders: A Regulatory DilemmaGispen-de Wied, C. / Stoyanova, V. / Yu, Y. / Isaac, M. / Pani, L. / de Andres-Trelles, F. et al. | 2012
- 812
-
Delayed- and early-onset hypotheses of antipsychotic drug action in the negative symptoms of schizophreniaLevine, S. Z. / Leucht, S. et al. | 2012
- 818
-
Geographical and temporal variations in clozapine prescription for schizophreniaNielsen, J. / Rø / ge, R. / Schjerning, O. / Sø / rensen, H. J. / Taylor, D. et al. | 2012
- 825
-
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorderVieta, E. / Montgomery, S. / Sulaiman, A. H. / Cordoba, R. / Huberlant, B. / Martinez, L. / Schreiner, A. et al. | 2012
- 836
-
Reduced plasma levels of asymmetric Di-Methylarginine (ADMA) in patients with alcohol dependence normalize during withdrawalFrieling, H. / Leitmeier, V. / Haschemi-Nassab, M. / Kornhuber, J. / Rhein, M. / Bleich, S. / Hillemacher, T. et al. | 2012
- 841
-
On assessing potential efficacy for vortioxetine in generalized anxiety disorderBaldwin, D. S. / Nutt, D. J. et al. | 2012
- 844
-
Neuropsychopharmacology across brain diseasesNutt, D. J. / Ove Ö / gren, S. / van Ree, J. M. et al. | 2012
- 847
-
Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trialBidzan, L. / Mahableshwarkar, A. R. / Jacobsen, P. / Yan, M. / Sheehan, D. V. et al. | 2012
- 858
-
Vortioxetine (Lu AA21004) 5mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United StatesRothschild, A. J. / Mahableshwarkar, A. R. / Jacobsen, P. / Yan, M. / Sheehan, D. V. et al. | 2012
- 867
-
Detection of the acute effects of hydrocortisone in the hippocampus using pharmacological fMRISymonds, C. S. / McKie, S. / Elliott, R. / William Deakin, J. F. / Anderson, I. M. et al. | 2012
- 875
-
Treatment of depression in first episode of schizophrenia: Results from EUFESTRybakowski, J. K. / Vansteelandt, K. / Szafranski, T. / Thys, E. / Jarema, M. / Wolfgang Fleischhacker, W. / Kahn, R. x. / Peuskens, J. et al. | 2012
- 883
-
Psychiatric comorbidity of patients on methadone maintenance treatment with a history of sexual abusePeles, E. / Potik, D. / Schreiber, S. / Bloch, M. / Adelson, M. et al. | 2012
- 892
-
Pre-treatment waking cortisol response and vulnerability to interferon α induced depressionEccles, J. / Lallemant, C. / Mushtaq, F. / Greenwood, M. / Keller, M. / Golding, B. / Tibble, J. / Haq, I. / Whale, R. et al. | 2012
- 897
-
Patients' acceptance of the deltoid application of risperidone long-acting injectionHeres, S. / Frobose, T. / Hamann, J. / Leucht, S. / Maino, K. / Reichhart, T. / Stiegler, M. / Kissling, W. et al. | 2012
- 902
-
Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophreniaBalla, A. / Schneider, S. / Sershen, H. / Javitt, D. C. et al. | 2012
- S1
-
S.01.01 Micro-RNA and psychiatric disordersMouillet-Richard, S. / Baudry, A. / Launay, J. M. / Kellermann, O. et al. | 2012
- S2
-
S.01.02 Analysis of whole genome biomarker expression in blood and brain; peripheral biomarkers in psychiatric disordersRollins, B. / Morgan, L. / Sequeira, P. A. / Moon, E. / Martin, M. / Malhotra, A. / Delbert, G. / Lencz, T. / Vawter, M. P. et al. | 2012
- S3
-
P.1.001 Deep brain stimulation increases dopamine, serotonin and noradrenaline in the prefrontal cortexvan Dijk, A. / Klompmakers, A. / Joosten, R. / Feenstra, M. / Denys, D. et al. | 2012
- S4
-
P.1.002 Role of 5-HT2A-receptor and a2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflowFranberg, O. I. / Marcus, M. M. / Svensson, T. H. et al. | 2012
- S5
-
P.1.003 Brain-derived neurotrophic factor as a biomarker of clinical response in bipolar disorder: 16-week follow-up studyGrande, I. / Stertz, L. / Vieta, E. / Kapczinski, F. et al. | 2012
- S6
-
P.1.004 Lower BDNF levels in schizophrenia than in control population: a case-control studyValiente, A. / Bernardo, M. et al. | 2012
- S8
-
P.1.007 Time-course analysis of hormonal and neuroplastic changes in rats exposed to prenatal stressLuoni, A. / Berry, A. / Cazzaniga, G. / Omati, E. / Racagni, G. / Cirulli, F. / Riva, M. A. et al. | 2012
- S9
-
P.1.008 Recruitment of the mTOR complex 1 by 5-HT6 receptors: potential role in the cognitive deficits of schizophreniaMeffre, J. / la Cour, C. M. / Watson, D. / Loiseau, F. / Fone, K. / Millan, M. J. / Bockaert, J. / Marin, P. et al. | 2012
- S10
-
P.1.009 Increased mRNA expression and release of neuropeptide S after REM sleep deprivation in ratAdori, C. / Barde, S. / Vas, S. / Toth, Z. / Koncol, K. / Pap, D. / Bagdy, G. / Reinscheid, R. K. / Hokfelt, T. et al. | 2012
- S11
-
P.1.010 Immunoglobulin G as a potential biomarker for posttraumatic stress disorder (PTSD)Herrmann, L. / Henes, K. / Bull, D. / Ionescu, I. A. / Holsboer, F. / Rein, T. / Touma, C. / Wotjak, C. T. / Schmidt, U. et al. | 2012
- S12
-
P.1.011 Identifying transcriptomic biomarkers for response to escitalopram in the inflammatory cytokine pathwayPowell, T. R. / Schalkwyk, L. C. / Breen, G. / Lawrence, T. / Pariante, C. / McGuffin, P. / Tansey, K. / Uher, R. / DSouza, U. M. et al. | 2012
- S13
-
P.1.012 Protein kinase C inhibition rescues manic-like behaviour and impairment of hippocampal cell proliferation induced by sleep deprivationAbrial, E. / Betourne, A. / Etievant, A. / Betry, C. / Bourcier-Lucas, C. / Scarna, H. / Lucas, G. / Haddjeri, N. / Lambas-Senas, L. et al. | 2012
- S14
-
P.1.013 Variants in catechol-o-methyltransferase gene are associated with impulsivity and executive function: relevance for major depressionPap, D. / Anderson, I. M. / Deakin, J. / Bagdy, G. Y. / Juhasz, G. et al. | 2012
- S16
-
P.1.016 The role of nitric oxide signalling in impulsive behavioursAlttoa, A. / Reuss, M. B. / Meyer, A. / Weber, H. / Kittel-Schneider, S. / Reif, A. et al. | 2012
- S17
-
P.1.017 Stress-induced enhancement of synaptic plasticity in the amygdala of mice depends on both glucocorticoid and -adrenergic activitySarabdjitsingh, R. A. / Kofink, D. / Karst, H. / de Kloet, E. R. / Joels, M. et al. | 2012
- S18
-
P.1.018 Modulation of glutamatergic synaptic transmission in prefrontal cortex by 5-HT2A receptorsBarre, A. / Bockaert, J. / Marin, P. / Becamel, C. et al. | 2012
- S19
-
P.1.019 Does the progranulin gene variability decrease the risk to develop bipolar disorder and schizophrenia?Palazzo, M. C. / Galimberti, D. / DellOsso, B. / Villa, C. / Fenoglio, C. / Kittel-Schneider, S. / Weigl, J. / Scarpini, E. / Reif, A. / Altamura, A. C. et al. | 2012
- S21
-
P.1.021 Longitudinal changes of N-acetyl-aspartate in early onset psychosisRapado-Castro, M. / Reig, S. / Graell, M. / Castro-Fornielles, J. / Gonzalez-Pinto, A. / Baeza, I. / Parellada, M. / Desco, M. / Arango, C. et al. | 2012
- S22
-
P.1.022 Association between genetic variations of the brain-derived neurotrophic factor and serotonin-1A receptor binding in the hippocampusHoflich, A. / Ungersboeck, J. / Vanicek, T. / Baldinger, P. / Friedl, M. / Wadsak, W. / Kranz, G. S. / Rujescu, D. / Kasper, S. / Lanzenberger, R. et al. | 2012
- S23
-
P.1.023 Association between oxytocin receptor single nucleotide polymorphism rs2254298 and prepulse inhibition in healthy subjectsLevin, R. / Raz, Y. / Laiba, E. / Edelman, S. / Bachner-Melman, R. / Heresco-Levy, U. / Ebstein, R. P. / Mankuta, D. et al. | 2012
- S24
-
P.1.024 A role for SIRT6 in cocaine addictionDikshtein, Y. / Barnea, R. / Gertler, A. / Peshty, V. / Maraton, D. / Kanfy, Y. / Cohen, H. Y. / Yadid, G. et al. | 2012
- S29
-
P.1.020 Forced swim stress enhances the survival of new dentate gyrus neurons in rat through a glucocorticoid receptor-dependent mechanismMifsud, K. R. / Gutierrez-Mecinas, M. / Collins, A. / Trollope, A. F. / Carter, S. D. / Reul, J. M. et al. | 2012
- S31
-
S.02.02 Neuropeptide S and anxietySlattery, D. A. / Naik, R. / Yen, Y. C. / Czibere, L. / Finger, B. / Mathe, A. A. / Wegener, G. / Landgraf, R. / Neumann, I. D. et al. | 2012
- S32
-
P.2.001 Differential effects of central oxytocin on social versus cued fearToth, I. / Neumann, I. D. / Slattery, D. A. et al. | 2012
- S33
-
P.2.002 Positive allosteric modulation of metabotropic glutamate 5 receptors prevents and reverses social discrimination deficits in ratsMorisot, N. / Clifton, N. E. / Loiseau, F. / Millan, M. J. et al. | 2012
- S34
-
P.2.003 Inhibition of the phosphatidylinositol-3 kinase cascade in corticolimbic structures: possible target to erase fear memoriesKritman, M. / Maroun, M. et al. | 2012
- S36
-
P.2.006 Ontogeny of cognitive impairment following prenatal infectionRichetto, J. / Meyer, U. / Calabrese, F. / Racagni, G. / Feldon, J. / Riva, M. et al. | 2012
- S37
-
P.2.007 Alterations in nociceptive responding and prefrontal chemokine expression in a rat model of depression: effects of chronic amitriptylineBurke, N. N. / Henry, R. / Chiu, S. / Finn, D. P. / Roche, M. et al. | 2012
- S38
-
P.2.008 Neurobiological correlates of cocaine-withdrawal induced anxiety after chronic treatment in ratsEl Hage, C. / Morel, A. L. / Luppi, P. H. / Berod, A. et al. | 2012
- S40
-
P.2.011 Decreased levels of allopregnanolone induced by oral contraceptives are associated with a reduction in social behaviour and sexual motivation in ratsBerretti, R. / Santoru, F. / Porcu, P. / Loche, L. / Corona, A. / Biggio, G. / Concas, A. et al. | 2012
- S41
-
P.2.012 Long-lasting memory abnormalities following exposure to the mouse defense test batteryPhilbert, J. / Belzung, C. / Griebel, G. et al. | 2012
- S42
-
P.2.013 Effects of melatonin on diurnal variations of spontaneous seizures and behavioural changes in kainate model of temporal lobe epilepsyPetkova, Z. / Pechlivanova, D. / Tchekalarova, J. et al. | 2012
- S43
-
P.2.014 Potentiation of donepezil efficiency profile by connexin inhibitors in age-related cognitive impairmentVandesquille, M. / Chauveau, F. / Decros-Tesolin, B. / Pierard, C. / Sebban, C. / Mouthon, F. / Beracochea, D. / Charveriat, M. et al. | 2012
- S44
-
P.2.015 An anxiolytic but not antidepressant-like activity of a novel positive modulator of mGlu4 receptor Lu AF21394Slawinska, A. / Wieronska, J. M. / Stachowicz, K. / Palucha-Poniewiera, A. / Pilc, A. / Uberti, M. A. / Bacolod, M. D. / Doller, D. et al. | 2012
- S45
-
P.2.016 Changes in basal and fluoxetine-induced adult neurogenesis and depression-related behaviours in transgenic S100B over-expressing miceSousa, V. / Egeland, M. / Svenningsson, P. et al. | 2012
- S47
-
P.2.019 BDNF/TrkB signaling in learning and memory: the effects of 7,8-dihydroxyflavone on object memoryBollen, E. / Akkerman, S. / Steinbusch, H. W. / Prickaerts, J. et al. | 2012
- S48
-
P.2.020 Housing conditions affect memory performance and drug efficacy in the ratAkkerman, S. / Prickaerts, J. / Steinbusch, H. W. / Blokland, A. et al. | 2012
- S51
-
S.03.01 Experimental clinical neuropsychopharmacology of antidepressantsHarmer, C. J. et al. | 2012
- S52
-
P.3.001 Ketamine-induced changes in anterior cingulate glutamate levels correlate with positive symptom generationStone, J. / Dietrich, C. / Edden, R. / Mehta, M. / De Simoni, S. / Reed, L. / Krystal, J. / Nutt, D. J. / Barker, G. et al. | 2012
- S53
-
P.3.002 Informative dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorderPower, R. / Muthen, B. / Henigsberg, N. / Mors, O. / Placentino, A. / Mendlewicz, J. / Maier, W. / McGuffin, P. / Lewis, C. M. / Uher, R. et al. | 2012
- S54
-
P.3.003 The need for antidepressants in chronic haemodialysisRoventa, C. / Ciocalteu, A. / Poenar, C. et al. | 2012
- S57
-
P.3.007 A common variant in human ErbB4 regulates GABA cerebrospinal fluid concentrationsVinkers, C. H. / Luykx, J. J. / Bakker, S. C. / Kahn, R. S. / Ophoff, R. et al. | 2012
- S58
-
P.3.008 SLC2A3: a new candidate gene for attention-deficit/hyperactivity disorderMerker, S. / Ziegler, G. / Weber, H. / Mayer, U. / Gro-Lesch, S. / Reif, A. / Lesch, K. P. et al. | 2012
- S59
-
P.3.009 Exploration of biological circadian rhythms in a patient with autism and a loss-of-function mutation of melatonin receptor type IPagan, C. / Chaste, P. / Delorme, R. / Drouot, X. / Chevenne, D. / Launay, J. M. / Bourgeron, T. et al. | 2012
- S60
-
P.3.010 Genetic variability at IMPA-2, INPP-1 and glycogen synthase kinase (GSK)-3b increases the risk of suicidal behaviour in bipolar patientsJimenez, E. / Arias, B. / Mitjans, M. / Goikolea, J. M. / Saiz, P. A. / Garcia-Portilla, M. P. / Bobes, J. / Vieta, E. / Benabarre, A. et al. | 2012
- S61
-
P.3.012 Effectiveness of naltrexone in the double blind placebo controlled clinical trial of naltrexone and guanfacine for heroin dependencePalatkin, V. / Krupitsky, E. / Zvartau, E. / Blokhina, E. / Bushara, N. / Tyurina, A. / Verbitskaya, E. et al. | 2012
- S62
-
P.3.013 Neurocognitive impairment in euthymic bipolar disorder: a functional magnetic resonance imaging study with a working memory taskCremaschi, L. / Palazzo, M. C. / Cristoffanini, M. / Dobrea, C. / Cinnante, C. / Avignone, S. / Sillani, A. / DellOsso, B. / Triulzi, F. M. / Altamura, A. C. et al. | 2012
- S63
-
P.3.014 An investigation of the role of the brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder (ASD) using the PET ligand [11C]Ro15-4513Mendez, M. A. / Myers, J. F. / Coghlan, S. / Stokes, P. / Erritzoe, D. / Horder, J. / Howes, O. / Lingford-Hughes, A. R. / Murphy, D. / Nutt, D. J. et al. | 2012
- S64
-
P.3.015 Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677CT polymorphism and psychiatric disorders in childrenKevere, L. / Purvina, S. / Bauze, D. / Zeibarts, M. / Piekuse, L. / Kreile, M. et al. | 2012
- S65
-
P.3.016 Oxcarbazepine, topiramate and lamotrigine in the treatment of alcohol cravingBajovic, B. / Zivkovic, N. / Djokic, G. / Pavicevic, D. et al. | 2012
- S66
-
P.3.017 Human impulsivity is not associated with variation in presynaptic striatal dopamine synthesis capacityStokes, P. R. / Benecke, A. / Shotbolt, J. P. / Nutt, D. J. / Howes, O. D. / Lingford-Hughes, A. R. et al. | 2012
- S67
-
P.3.018 Reduced subjective response to acute ethanol administration among young men with the bipolar phenotypeYip, S. / Doherty, J. / Wakeley, J. / Saunders, K. / Tzagarakis, C. / de Wit, H. / Goodwin, G. M. / Rogers, R. D. et al. | 2012
- S69
-
P.3.021 Potential benefits of slow titration of paroxetine treatment in elderly population: 6-month results from a naturalistic settingGibiino, S. / Fabbri, C. / Serretti, A. et al. | 2012
- S70
-
P.3.022 Deep brain stimulation in the lateral orbitofrontal cortex impairs spatial reversal learningKlanker, M. / Post, G. / Joosten, R. / Feenstra, M. / Denys, D. et al. | 2012
- S71
-
P.3.023 Metabolic risk after six months of treatment with second-generation antipsychotics in antipsyehotic-naive children and adolescentsDiaz-Caneja, C. M. / Giraldez-Quiroga, M. / Merchan-Naranjo, J. / Pina-Camacho, L. / Tapia-Casellas, C. / Rodriguez-Latorre, P. / Arango, C. et al. | 2012
- S72
-
P.3.024 Brain activation associated with attentional bias in smokers is modulated by a dopamine antagonistLuijten, M. / Veltman, D. J. / Smits, M. / Pepplinkhuizen, L. / Franken, I. H. et al. | 2012
- S74
-
P.3.027 A single dose of the antidepressant fluoxetine modulates emotional processing in young adult volunteersCapitao, L. / Murphy, S. / Harmer, C. et al. | 2012
- S75
-
P.3.028 Antenatal depression and infant sleep 6 months postpartum: examining the moderating effects of the 5-HTTLPR and temperamentNetsi, E. / Murphy, S. E. / Wulff, K. / Ramchandani, P. G. et al. | 2012
- S76
-
P.3.029 Chronic cannabis use and dopamine synthesis capacity: an [18F]-DOPA positron emission tomography studyBloomfield, M. A. / Morgan, C. J. / Egerton, A. / Kapur, S. / Curran, H. V. / Howes, O. D. et al. | 2012
- S77
-
P.3.030 Functional magnetic resonance imaging of increased working memory load after traumatic brain injuryLivny-Ezer, A. / Weiser, M. / Kushnir, T. / Harnof, S. / Tomasi, D. / Biegon, A. et al. | 2012
- S78
-
P.3.031 Is there enough evidence for add-on treatment with benzodiazepines in schizophrenia? A meta-analysis of randomised controlled trialsDold, M. / Leucht, S. et al. | 2012
- S81
-
S.04.01 Plasticity based therapeutics for the treatment of mood disordersZarate, C. / Furey, M. / Duncan, W. / Cornwell, B. / Sarasso, S. / Tononi, G. et al. | 2012
- S82
-
S.04.02 Predictive animal models of depressionFuchs, E. et al. | 2012
- S86
-
P.4.004 P-glycoprotein inhibition enhances transport of the antidepressant imipramine across the blood-brain barrierOBrien, F. E. / Clarke, G. / Fitzgerald, P. / Dinan, T. G. / Griffin, B. T. / Cryan, J. F. et al. | 2012
- S87
-
P.4.005 Effect of antidepressant drugs on dopamine D2 and somatostatin Sst5 receptor heterodimerisation - fluorescence in vitro studiesSzafran, K. / Lukasiewicz, S. / Faron-Gorecka, A. / Gaska, M. / Kusmider, M. / Solich, J. / Dziedzicka-Wasylewska, M. et al. | 2012
- S88
-
P.4.006 Ketamine infusion in bipolar disorder resistant to treatment with antidepressantsPermoda-Osip, A. / Adamski, R. / Bartkowska-Sniatowska, A. / Chlopocka-Wozniak, M. / Skibinska, M. / Rybakowski, J. K. et al. | 2012
- S89
-
P.4.007 Pharmacological modulation of epigenetic regulation of BDNF-TrkB signaling in differentiated SH-SY5Y human neuroblastoma cellsBoulle, F. / Hove Vd, D. L. / Goethals, A. / Chinwang, J. / Pannaye, P. / Romano, A. / Lanfumey, L. / Steinbusch, H. W. / Kenis, G. et al. | 2012
- S91
-
P.4.010 Local gene knockdown of Adcy8, a potential candidate gene for a mural endophenotype of bipolar disorderde Visser, L. / Kuijlaars, E. / Kostrzewa, E. / van Lith, H. A. / Mitsogiannis, M. D. / Oppelaar, H. / Collier, D. A. / Kas, M. J. et al. | 2012
- S92
-
P.4.012 Behavioural and molecular alterations in FKBP52+/- mice under basal and chronic stress conditionsHartmann, J. / Wagner, K. V. / Hausch, F. / Rein, T. / Schmidt, U. / Touma, C. / Holsboer, F. / Muller, M. B. / Schmidt, M. V. et al. | 2012
- S93
-
P.4.013 Assessing CRH-mediated anxiogenic and anxiolytic effects using region-and neurotransmitter-specific CRH overexpressing miceDedic, N. / Ableitner, M. / Touma, C. / Wang, X. D. / Kuhne, C. / Schmidt, M. V. / Wurst, W. / Holsboer, F. / Refojo, D. / Deussing, J. M. et al. | 2012
- S94
-
P.4.014 Deep brain stimulation in treatment-resistant depression in miceDournes, C. / Beeske, S. / Belzung, C. / Griebel, G. et al. | 2012
- S95
-
P.4.015 Gene expression profile associated with major depression and with antidepressant responseCattaneo, A. / Uher, R. / Breen, G. / McGuffin, P. / Gennarelli, M. / Pariante, C. M. et al. | 2012
- S96
-
P.4.016 GABA-B1 receptor subunit isoforms differentially mediate susceptibility to depression-related behaviour following early-life stressFelice, D. / OLeary, O. F. / Bettler, B. / Cryan, J. F. et al. | 2012
- S97
-
P.4.017 Cortisol decreases hippocampal neurogenesis by regulating the enzyme serum- and glucocorticoid-regulated kinase 1Anacker, C. / Zunszain, P. A. / Cattaneo, A. / Musaelyan, K. / Thuret, S. / Price, J. / Pariante, C. M. et al. | 2012
- S98
-
P.4.019 Targeting cognitive impairment in anxiety disorders: transcriptional actions of glucocorticoid receptor modulatorsUdeh, C. T. / Waite, E. J. / Thomson, F. J. / Lightman, S. L. et al. | 2012
- S99
-
P.4.020 Fluoxetine acts not only as an antidepressant: inhibitory effect on murine melanoma growthGrygier, B. / Kubera, M. / Urbanska, K. / Arteta, B. / Lason, W. et al. | 2012
- S100
-
P.4.021 MicroRNAs as novel antidepressant targets in refractory depression: converging effects of ketamine and electroconvulsive shock therapyOConnor, R. M. / Dinan, T. G. / Cryan, J. F. et al. | 2012
- S101
-
P.4.022 Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressantsPelizzari, M. / Tardito, D. / Mallei, A. / Corna, S. / Treccani, G. / Bocchio-Chiavetto, L. / Racagni, G. / Popoli, M. et al. | 2012
- S103
-
Author Index| 2012
- S107
-
Keyword Index| 2012
- S111
-
PL.06.01 Opioid systems: probing molecular processes of brain functionKieffer, B. L. et al. | 2012
- S113
-
S.01.04 Pharmacological treatment of pathological gambling: opioid antagonists and other addiction-related pharmacological treatmentsGrant, J. et al. | 2012
- S116
-
S.04.03 Sleep deprivation as an animal model of bipolar mania: antimanic and proliferative effects of protein kinase C inhibitionAbrial, E. / Betourne, A. / Etievant, A. / Betry, C. / Bourcier-Lucas, C. / Scarna, H. / Lucas, G. / Haddjeri, N. / Lambas-Senas, L. et al. | 2012
- S118
-
S.05.01 EpidemiologyBeesdo-Baum, K. / Wittchen, H. U. et al. | 2012
- S119
-
S.05.03 Early interventionUtens, E. M. et al. | 2012
- S120
-
S.07.01 Alterations in nociceptive responding and prefrontal chemokine expression in a rat model of depression: effects of chronic amitriptylineBurke, N. N. / Henry, R. / Chiu, S. / Finn, D. P. / Roche, M. et al. | 2012
- S123
-
S.08.01 Potential biomarkers and genetic findings in ADHDTaurines, R. / Renner, T. J. / Schecklmann, M. / Grunblatt, E. / Walitza, S. / Thome, J. / Gerlach, M. / Romanos, M. et al. | 2012
- S124
-
S.08.04 MicroRNA in schizophrenia and developmental disordersCairns, M. J. et al. | 2012
- S125
-
S.09.02 Predicting cognitive remediation outcome with genesCavallaro, R. / Bosia, M. / Smeraldi, E. et al. | 2012
- S126
-
S.10.02 Alzheimers disease and frontotemporal dementia: MRIFilippi, M. et al. | 2012
- S127
-
S.11.01 Transcriptional dysregulation of 5-HT1A receptors in psychiatric disordersAlbert, P. R. / Le Francois, B. / Millar, A. M. / Czesak, M. et al. | 2012
- S128
-
S.12.02 Targeting VGLUT2 in dopamine neurons affects the brain reward systemWallen-Mackenzie, A. / Arvidsson, E. / Restrepo, E. / Pupe Johann, S. / Perland, E. / Nordenankar, K. / Kullander, K. / Alsio, J. / Leao, R. et al. | 2012
- S130
-
S.13.03 Immunotherapy in prion diseasesCarnaud, C. / Bachy, V. / Iken, S. / Gourdain, P. et al. | 2012
- S131
-
S.14.02 Update of neuroimaging in social anxiety disorderBruhl, A. B. / Rufer, M. / Herwig, U. et al. | 2012
- S132
-
S.14.04 Pharmacological treatment of social phobia: efficacy, acceptability and unmet needsBaldwin, D. S. et al. | 2012
- S133
-
S.15.04 Role of baclofen and modulation at GABAB receptor in treating addiction: a clinical prospectiveLeggio, L. et al. | 2012
- S135
-
S.18.03 Ketamine and the potential role for rapid-acting antidepressantsMonteggia, L. et al. | 2012
- S137
-
S.20.03 Genetic susceptibility underlying cognitive flexibilityde Visser, L. / Molenhuis, R. T. / Broekhoven, M. H. / Kas, M. J. et al. | 2012
- S138
-
S.21.02 Deep brain stimulation of the habenula for treatment-resistant depressionSartorius, A. / Vollmayr, B. et al. | 2012
- S139
-
S.22.02 Changes in dopamine function in depressionMartin Soelch, C. et al. | 2012
- S143
-
S.26.01 Impact of childhood ADHD symptoms on later depressive disordersPurper-Ouakil, D. / Le Strat, Y. / Falissard, B. / Gorwood, P. et al. | 2012
- S145
-
S.27.03 Hypocretin/orexin in sleep and mood disordersFabre, V. / Rachalski, A. / Bernard, J. F. / Lin, J. S. / Hamon, M. / Vodjdani, G. / Adrien, J. et al. | 2012
- S146
-
S.28.02 The roles of specific neuronal population of the striatum in addiction and motor control: a molecular and transgenic approachde Kerchove dExaerde, A. / Durieux, P. F. / Schiffmann, S. N. et al. | 2012
- S149
-
E.02.04 Concluding remarksWasserman, D. et al. | 2012
- S150
-
E.05.01 The unmet needs in the treatment of schizophreniaBitter, I. / Galderisi, S. et al. | 2012
- S151
-
E.05.03 The unmet needs in the treatment of alcohol dependenceGorwood, P. et al. | 2012
- S153
-
P.1.a.002 Schizophrenic phenotype and treatment responseJun, T. et al. | 2012
- S155
-
P.1.a.005 Lithium-induced changes in circadian gene expression in lymphoblastoid cell lines of bipolar patientsKittel-Schneider, S. / Schreck, S. / Reif, A. et al. | 2012
- S156
-
P.1.a.007 Toll-like receptor 2 polymorphisms are associated with poor concentration in schizophrenia patients in a Korean populationLee, S. M. / Kang, W. S. / Paik, J. W. / Kim, J. W. / Song, J. Y. et al. | 2012
- S157
-
P.1.a.008 CYP2D6 polymorphisms and dose of antidepressants in major depression: a naturalistic studyGressier, F. / Verstuyft, C. / Hardy, P. / Becquemont, L. / Corruble, E. et al. | 2012
- S158
-
P.1.a.010 BDNF Val66Met polymorphism in major depression and in therapeutic responseFeher, A. / Graef, A. / Galfi, M. / Juhasz, A. / Janka, Z. et al. | 2012
- S159
-
P.1.a.012 A functional NPSR1 gene polymorphism and family relations influence mood and anxiety disorders in a longitudinal studyLaas, K. / Reif, A. / Kiive, E. / Deckert, J. / Lesch, K. P. / Veidebaum, T. / Harro, J. et al. | 2012
- S160
-
P.1.a.013 T102c polymorphism of serotonin-2a receptor gene in schizophrenia: association with cognitive impairment and soft neurological signsPoyraz, B. C. / Ozcetin, A. / Aksoy Poyraz, C. / Bozhuyuk, E. / Bolat, N. / Balcioglu, I. / Ozkilic, A. C. / Genc, Z. S. / Cengiz, M. et al. | 2012
- S162
-
P.1.a.016 Progranulin gene variability could decrease the risk to develop bipolar disorder and schizophreniaPalazzo, M. C. / DellOsso, B. / Galimberti, D. / Reif, A. / Villa, C. / Kittel-Schneider, S. / Scarpini, E. / Altamura, A. C. et al. | 2012
- S163
-
P.1.b.002 Microscopic particles in fresh cerebrospinal fluid in twins with schizophrenia and bipolar disorder and in healthy subjectsJohansson, V. / Nybom, R. / Wetterberg, L. / Hultman, C. M. / Cannon, T. D. / Johansson, A. M. / Ekman, C. J. / Landen, M. et al. | 2012
- S164
-
P.1.b.003 The impact of regular cannabis use on human brain structureLorenzetti, V. / Solowij, N. / Fornito, A. / Lubman, D. I. / Takagi, M. / Harding, I. H. / Pantelis, C. / Seal, M. / Yucel, M. et al. | 2012
- S165
-
P.1.b.005 Interleukin-6 and personality traits in suicide attemptersJokinen, J. / Isung, J. / Mobarrez, F. / Asberg, M. / Nordstrom, P. / Aeinehband, S. / Piehl, F. et al. | 2012
- S166
-
P.1.c.001 Effects of (S)-3,4-DCPG, a selective agonist of glutamate mGlu8 receptors, on sleep and wakefulness in the ratScesa, G. L. / Cavas, M. / Muela, A. T. / Navarro, J. F. et al. | 2012
- S168
-
P.1.c.004 Study of the effects of alpha-lipoic acid, benfotiamine and combined vitamin preparation on pain and inflammation in ratsDoncheva, N. / Mihaylova, A. / Getova, D. et al. | 2012
- S169
-
P.1.c.006 Naltrexone effects on aggression in male mice with positive fighting historyKudryavtseva, N. N. / Bondar, N. P. / Smagin, D. A. et al. | 2012
- S171
-
P.1.c.009 The effects of polyamidehydroxyurethane-coated silver nanoparticles on morphine-induced conditioned place preference in ratsCiubotariu, D. / Bindar, D. / Melnig, V. / Tartau, L. et al. | 2012
- S173
-
P.1.c.012 Mechanisms of antidepressant drugs on neurite outgrowth and synaptic proteins in rat hippocampal cellsKim, J. G. / Park, S. W. / Lee, J. G. / Lee, C. H. / Seo, M. K. / Cho, H. Y. / Fang, Z. H. / Kim, Y. H. et al. | 2012
- S174
-
P.1.c.014 Etanercept effect on aortic nitric oxide dependent vasorelaxation in an unpredictable chronic mild stress model of depression in ratsBayramgurler, D. / Karson, A. / Yazir, Y. / Komsuoglu Celikyurt, I. / Utkan, T. et al. | 2012
- S176
-
P.1.c.017 A simple, reproducible and reliable method of gradual forced administration of psychotropic drugs in a drug dependence model in ratsLebedev, A. A. / Shabanov, P. D. et al. | 2012
- S177
-
P.1.c.019 Effects of novel dopaminergic derivatives on depression-like behaviour: a pilot studyFedotova, J. / Barishpolec, V. et al. | 2012
- S178
-
P.1.c.020 "Look me in the face!": short-term SSRI administration reverts avoidant ocular face exploration in subjects at risk for psychopathologyDi Simplicio, M. / Doallo, S. / Costoloni, G. / Rohenkohl, G. / Nobre, A. C. / Harmer, C. J. et al. | 2012
- S179
-
P.1.c.022 Effects of association of ethanol and naltrexone on short- and long-term memory of micePinto, G. G. / Freire, M. D. / Patrocinio, M. C. / Fonteles, M. M. / Do Vale, O. C. / Soares, P. M. / Magela, M. F. / Severo, A. H. / Viana, G. S. / Vasconcelos, S. M. et al. | 2012
- S181
-
P.1.c.025 Determination of alpha-lipoic acid and acetyl-L-carnitine administration effects in a Parkinson animal model induced by 6-OHDABorella, V. M. / Belchior, L. D. / Dos Santos, J. V. / Nascimento, N. L. / De Souza, M. R. / Monte, A. S. / Medeiros, C. D. / Cordeiro, R. C. / Carvalho, A. F. / Macedo, D. S. et al. | 2012
- S182
-
P.1.d.002 The antidepressant agomelatine improves unpredictable chronic mild stress-induced memory deterioration in miceUlak, G. / Mutlu, O. / Komsuoglu Celikyurt, I. / Akar, F. / Erden, F. et al. | 2012
- S184
-
P.1.d.005 Modelling negative symptoms of schizophrenia: combined neonatal PCP and social isolation causes social interaction deficits in ratsMcintosh, A. L. / Ballard, T. M. / Steward, L. J. / Moran, P. M. / Fone, K. C. et al. | 2012
- S185
-
P.1.d.007 Selective NMDA-NR2B receptor antagonist with neurogenic properties, Ro 25-6981 facilitates repeated spatial learning in adult ratsSolovieva, O. A. / Proshin, A. T. / Storozheva, Z. I. / Sherstnev, V. V. et al. | 2012
- S187
-
P.1.d.010 Acute effects of an inverse agonist selective for a5 GABAA receptors on rat behaviour in the forced swim testSamardzic, J. / Batinic, B. / Biawat, P. / Obradovic, D. I. / Cook, J. M. / Savic, M. M. et al. | 2012
- S188
-
P.1.d.012 Conditioned place aversion induced by different neuroleptics in mice: an animal model to predict adherence to treatmentAramini, T. C. / Fukushiro, D. F. / Ceccon, L. M. / Hollais, A. W. / Mari-Kawamoto, E. / Josino, F. S. / Costa, J. M. / Saito, L. P. / Frussa-Filho, R. et al. | 2012
- S189
-
P.1.d.015 Quick but lazy? Locomotor hyperactivity and motivational deficits in the Nosl-knockdown miceAlttoa, A. / Post, A. / Prost, F. / Lesch, K. P. / Reif, A. et al. | 2012
- S190
-
P.1.d.016 Effects of PWZ-029, an a5GABAA receptor inverse agonist, on scopolamine-induced spatial learning deficits in the water mazeJoksimovic, S. M. / Timic, T. / Radulovic, T. / Rallapalli, S. / Milinkovic, M. M. / Divljakovic, J. M. / Batinic, B. / Cook, J. M. / Savic, M. M. et al. | 2012
- S191
-
P.1.e.001 Brain default mode network derived from task-specific functional MRIGanger, S. / Hahn, A. / Sladky, R. / Kranz, G. / Hoflich, A. / Losak, J. / Vanicek, T. / Windischberger, C. / Kasper, S. / Lanzenberger, R. et al. | 2012
- S192
-
P.1.e.002 Association between catechol-O-methyltransferase genotype and serotonin-1a receptor binding using positron emission tomographyBaldinger, P. / Hahn, A. / Wadsak, W. / Friedl, M. / Kraus, C. / Mitterhauser, M. / Ungersboeck, J. / Rujescu, D. / Kasper, S. / Lanzenberger, R. et al. | 2012
- S193
-
P.1.e.004 Brain serotonin neurotransmission and affect regulation in humans: a positron emission tomography studySelvaraj, S. / Turkheimer, F. / Faulkner, P. / Mouchlianitis, E. / Roiser, J. P. / McGuire, P. / Cowen, P. J. / Howes, O. et al. | 2012
- S195
-
P.1.e.007 Elevated prefrontal cortex monoamine oxidase-A binding in major depressive disorder and comorbid borderline personality disorderKolla, N. / Wilson, A. A. / Houle, S. / Meyer, J. H. et al. | 2012
- S196
-
P.1.e.009 Whole brain relationship of serotonergic receptorsSavli, M. / Mitterhauser, M. / Ding, Y. S. / Hahn, A. / Neumeister, A. / Bauer, A. / Wadsak, W. / Isfahani, S. A. / Hoflich, A. / Lanzenberger, R. et al. | 2012
- S197
-
P.1.e.010 5-HT1B receptor gene status alters 5-HT1A binding as investigated in vivo by [carbonyl-11C]WAY-100635 PETKraus, C. / Vanicek, T. / Wadsak, W. / Baldinger, P. / Hartmann, A. / Mitterhauser, M. / Ungersboeck, J. / Rujescu, D. / Kasper, S. / Lanzenberger, R. et al. | 2012
- S198
-
P.1.e.012 Effect of interferon-alfa on cortical glutamate in patients with hepatitis C: a proton magnetic resonance spectroscopy studyGodlewska, B. R. / Taylor, M. J. / Near, J. / Christmas, D. / Potokar, J. / Collier, J. / Klenerman, P. / Barnes, E. / Cowen, P. J. et al. | 2012
- S199
-
P.1.e.013 The Bcl2 gene polymorphism rs956572 modulates anterior cingulate cortex glutamate levels in euthymic subjects with bipolar I disorderSoeiro-de-Souza, M. G. / Machado-Vieira, R. / Moreno, R. A. et al. | 2012
- S200
-
P.1.e.015 Video-confrontation in anorexia nervosa: a functional magnetic resonance studyHernandez-Ribas, R. / Via, E. / Soriano-Mas, C. / Sanchez, I. / Castro, R. / Martinez-Zalacain, I. / Pujol, J. / Menchon, J. M. / Fernandez-Aranda, F. / Cardoner, N. et al. | 2012
- S201
-
P.1.e.017 Consistency of resting-state networks in a multi-centre datasetHuf, W. / Kalcher, K. / Boubela, R. / Kasper, S. / Moser, E. / Windischberger, C. et al. | 2012
- S202
-
P.1.e.018 Brain regions associated with the risk and resilience for bipolar I disorder: a voxel based MRI studySimsek, F. / Eker, M. C. / Kitis, O. / Haznedaroglu, D. I. / Cinar, C. / Bilgi, M. M. / Isikli, S. / Coburn, K. / Gonul, A. S. et al. | 2012
- S203
-
P.1.e.020 Neural correlates of inspiratory breathing restriction: an fMRI pilot studyMaslowski, N. / Huber, A. / Westphal, D. / Wittchen, H. U. / Lueken, U. et al. | 2012
- S205
-
P.1.g.001 The 5-HT6 receptor agonist EMD 386088 promotes cognitive flexibility in ratsRafa, D. / Nikiforuk, A. et al. | 2012
- S206
-
P.1.g.003 The effects of chronic lower back pain on cognitive functionWesnes, K. / Annas, P. et al. | 2012
- S208
-
P.1.g.007 Differences of clinical and psychological characteristics among clusters of personality disorder by DSM-IV text revision criteriaLee, J. Y. / Sakong, J. K. / Cheon, E. J. / Song, S. H. / Koo, B. H. et al. | 2012
- S209
-
P.1.g.009 Effect of agmatine on cognition and hippocampal brain-derived neurotrophic factor expression in chronic unpredictable mild stressYazir, Y. / Gumru, S. / Yarci, E. / Cabadak, H. / Aydin, B. / Utkan, T. / Aricioglu, F. et al. | 2012
- S210
-
P.1.g.011 No deleterious effect on mood and cognition after ten repetitive transcranial magnetic stimulation sessions: a double-blind sham studyMoulier, V. / Allard, A. C. / Sidhoumi, D. / Gaudeau-Bosma, C. / Braha, S. / Bouaziz, N. / Januel, D. et al. | 2012
- S212
-
P.1.g.014 Automated tests of attention and information processing as an alternative to the Paced Auditory Serial Addition Test (PASAT) in clinical trials in multiple sclerosisWesnes, K. / Swartz, J. / Jongen, P. J. et al. | 2012
- S213
-
P.1.g.016 Modulation of nicotinic acetylcholinergic receptors differentially affects auditory event related potentials in awake ratsBiermans, R. / Drinkenburg, W. H. / Ahnaou, A. et al. | 2012
- S214
-
P.1.g.018 Emotional coping with stigma of schizophrenia - positive implicit attitudes associated with brain circuitry of emotion regulationRaij, T. T. / Riekki, T. J. et al. | 2012
- S216
-
P.1.h.002 The impacts of depression, sleep quality and somatic symptoms for perceived stress of nurses on rotating shift and daytime fixed schedulesHo, K. P. / Choi, M. et al. | 2012
- S217
-
P.1.h.004 Mental health service availability and suicidality in different regions of SloveniaJagodic, H. K. / Pregelj, P. / Agius, M. et al. | 2012
- S218
-
P.1.i.001 Psychiatric phenomena among cardiologic patients who have survived a clinical deathRenemane, L. / Straume, Z. / Kupca, B. et al. | 2012
- S219
-
P.1.i.002 Relationship between psychological profile and postoperative pain of living donorYoo, S. / Shin, K. / Wang, H. J. / Kim, B. / Noh, J. S. et al. | 2012
- S220
-
P.1.i.004 Neu-P11: a novel drug for the treatment of insomnia and central sensitivity syndrome symptoms - results of a Phase-Ib studyKatz, A. / Metzger, D. / Staner, L. / Pross, N. / Cornette, F. / Guichard, N. / Laudon, M. / Nir, T. / Zisapel, N. et al. | 2012
- S222
-
P.1.i.007 Psychoimmune interactions in women of reproductive age with endometriosisNasyrova, R. et al. | 2012
- S223
-
P.1.i.009 Some urban legends of CNS clinical trial methodology: unsuccessful solutions to the problem of failed trialsWilliams, J. B. / Popp, D. / Reines, S. / Detke, M. J. et al. | 2012
- S225
-
P.2.a.002 Depressive state and personality trait as predictive factors for the suicide risk among the low-income general populationHa, J. H. / Park, D. H. / Yoon, D. H. et al. | 2012
- S226
-
P.2.a.005 Impairment of kidney function during long-term lithium treatment: are men more vulnerable?Abramowicz, M. / Drogowska, J. / Chlopocka-Wozniak, M. / Rybakowski, J. et al. | 2012
- S227
-
P.2.a.007 Lu AA21004, a multimodal psychotropic agent, in the open-label, long-term treatment of major depressive disorderBaldwin, D. S. / Hansen, T. / Florea, I. et al. | 2012
- S229
-
P.2.a.010 Patient-reported cognitive symptoms and a patient-reported outcome measure of cognitive function in depressionForsyth, B. / Fehnel, S. / Danchenko, N. / Francois, C. / Brevig, T. et al. | 2012
- S230
-
P.2.a.012 Evidence that self-reported sleep impacts on momentary affect in daily life and predicts follow-up depressive symptomatologyde Wild-Hartmann, J. A. / Wichers, M. / Derom, C. / Thiery, E. / van Bemmel, A. L. / van Os, J. / Simons, C. J. et al. | 2012
- S232
-
P.2.a.015 Association between mood disorder questionnaire and bipolar spectrum disorder criteria in major depressive disorderLee, H. / Hahn, S. / Kwon, Y. / Jeong, H. / Shim, S. et al. | 2012
- S233
-
P.2.a.017 Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levelsMadhoo, M. / Roth, R. M. / Keefe, R. S. / Sambunaris, A. / Scheckner, B. / Nielsen, J. / Adeyi, B. / Wu, J. / Lasser, R. et al. | 2012
- S234
-
P.2.a.019 BDNF changes during antidepressant treatment: the predictive value for therapeutic outcomeDelini-Stula, A. / Holsboer-Trachsler, E. / Mikoteit, T. H. / Hemmeter, U. / Beck, J. / Eckert, A. et al. | 2012
- S235
-
P.2.a.020 A systematic review of treatment effects of antidepressants on work productivity outcomesLam, R. W. / McLeod, J. / Woo, C. / Michalak, E. E. / Yatham, L. N. / Bond, D. J. et al. | 2012
- S236
-
P.2.a.022 A comparison of work productivity outcome scales for depression clinical trialsLam, R. W. / Parikh, S. V. / Ramasubbu, R. / Yatham, L. N. / Michalak, E. E. / Manjunath, C. V. et al. | 2012
- S238
-
P.2.a.025 Similar seizure characteristics of electroconvulsive therapy and magnetic seizure therapy in treatment-resistant depressionKayser, S. / Bewernick, B. H. / Hurlemann, R. / Schlaepfer, T. E. et al. | 2012
- S239
-
P.2.a.027 Decreased fronto-limbic volumes in treatment-resistant major depressive disorderSerra-Blasco, M. / Portella, M. J. / De Diego-Adelno, J. / Vives-Gilabert, Y. / Gomez-Anson, B. / Santos, A. / Puigdemont, D. / Perez, E. A. et al. | 2012
- S240
-
P.2.a.029 The role of serotonergic genes and environmental stress on the development of depressive symptoms and neuroticismMandelli, L. / Antypa, N. / Nearchou, F. A. / Vaiopoulos, C. / Stefanis, C. N. / Serretti, A. / Stefanis, N. et al. | 2012
- S241
-
P.2.b.001 Effect of repeated co-treatment with fluoxetine and risperidone on the brain-derived neurotrophic factor protein level in ratsRogoz, Z. / Sowa-Kucma, M. et al. | 2012
- S242
-
P.2.b.003 Relationship between plasma fluvoxamine levels and clinical improvement in OCDMarazziti, D. / Baroni, S. / Picchetti, M. / Massimetti, G. / Vatteroni, E. / Lombardi, A. / Palego, L. / Catena-DellOsso, M. et al. | 2012
- S243
-
P.2.b.005 The effects of the multimodal antidepressant Lu AA21004 on attention and vigilance measured as EEG activity in the ratSanchez, C. / Robichaud, P. J. / Pehrson, A. / Leiser, S. C. et al. | 2012
- S244
-
P.2.b.007 The pathophysiological role of cortisol and DHEA in perinatal depressionSuh, H. S. / Ahn, R. S. / Kim, C. H. / Kim, Y. K. / Lee, K. S. / Yook, K. H. et al. | 2012
- S245
-
P.2.b.008 In vitro effects of the multimodal antidepressant Lu AA21004 at human and rat 5-HT1A, 5-HT1B, 5-HT3 and 5-HT7 receptors, and 5-HT transportersSanchez, C. / Westrich, L. / Zhong, H. / Nielsen, S. M. / Boyle, N. / Hentzer, M. / Fredriksen, K. / Stensbol, T. B. et al. | 2012
- S246
-
P.2.b.010 Effects of chronic mild stress and electroconvulsive seizure on memory functions in ratsWiborg, O. / Henningsen, K. / Woldbye, D. / Bouzinova, E. et al. | 2012
- S248
-
P.2.b.013 Does the early response to deep brain stimulation in depression represent a placebo or electrode insertion effect?Perez-Caballero, L. / Perez-Egea, R. / Puigdemont, D. / Molet, J. / Mico, J. A. / Perez, V. / Berrocoso, E. et al. | 2012
- S249
-
P.2.b.016 GABAB receptor subunit isoforms differentially mediate susceptibility to early-life stress-induced depression-related behaviourFelice, D. / OLeary, O. F. / Bettler, B. / Cryan, J. F. et al. | 2012
- S250
-
P.2.c.001 Triiodothyronine effects on treatment of major depression with escitalopram in womenBunevicius, R. / Liutkus, S. / Kunigelis, Z. / Kaminskaite, T. / Gulbinaite, N. / Mickuviene, N. et al. | 2012
- S251
-
P.2.c.003 Mirtazapine in diabetic patientsBahk, W. / Song, H. R. / Wang, H. R. / Woo, Y. S. / Kim, K. S. / Jun, T. Y. / Lee, K. H. / Lee, S. Y. et al. | 2012
- S253
-
P.2.c.006 Efficacy and clinical relevance of vilazodone in the treatment of major depressive disorder: a pooled analysis of phase III clinical trialsKhan, A. / Song, W. / Edwards, J. / Ruth, A. et al. | 2012
- S254
-
P.2.c.008 Efficacy of venlafaxine extended release monotherapy for first episode depression with painful physical symptomsHuang, X. / Li, C. / Luo, Y. L. / Ji, J. L. / Wang, B. et al. | 2012
- S255
-
P.2.c.010 The multimodal antidepressant Lu AA21004: open-label long-term safety and tolerability study in major depressive disorderFlorea, I. / Dragheim, M. / Loft, H. et al. | 2012
- S256
-
P.2.c.012 Predictors of response and remission during an open-label, 10-week trial with selegiline transdermal systemPortland, K. / Jung, S. / Jang, S. / Pae, C. / Patkar, A. A. et al. | 2012
- S257
-
P.2.c.013 Efficacy and safety of selegiline transdermal system for atypical depression: pooled analysis of short-term placebo-controlled trialsPatkar, A. A. / Jang, S. / Portland, K. / Jung, S. / Pae, C. / Nelson, J. C. et al. | 2012
- S258
-
P.2.c.015 A randomised, double-blind, placebo-controlled, active-referenced study of the multimodal antidepressant Lu AA21004 in the treatment of elderly depressed patientsKatona, C. / Hansen, T. / Olsen, C. K. et al. | 2012
- S260
-
P.2.c.018 Morningness and eveningness changes after agomelatine treatment in major depressionCorruble, F. / Frank, E. / Gressier, F. / Courtet, P. / Vaiva, G. / Bayle, F. / Llorca, P. / Kupfer, D. / Gorwood, P. et al. | 2012
- S261
-
P.2.c.020 The efficacy and safety of levomilnacipran in the treatment of major depressive disorder: results from a phase III clinical trialBose, A. / Chen, C. / Gommoll, C. / Ruth, A. / Terner-Rosenthal, J. et al. | 2012
- S262
-
P.2.c.022 Levomilnacipran in the treatment of major depressive disorder: functional health and well-being efficacy results from a phase III trialBlum, S. / Tourkodimitris, S. / Ruth, A. / Terner-Rosenthal, J. et al. | 2012
- S263
-
P.2.c.023 Long-term safety and tolerability of the multimodal antidepressant Lu AA21004 in subjects with major depressive disorderAlam, M. / Jacobsen, P. L. / Chen, Y. / Serenko, M. / Mahableshwarkar, A. R. et al. | 2012
- S264
-
P.2.c.025 Preliminary findings of the rest-activity cycles in patients with major depression following agomelatine and sertraline treatmentWulff, K. / Laigle, L. / Hajak, G. / Kasper, S. et al. | 2012
- S265
-
P.2.c.027 Trazodone modified-release tablets in the treatment of moderate to severe depressionCeskova, E. et al. | 2012
- S266
-
P.2.c.028 Candidate genes expression profile associated with antidepressants response: baseline predictors and longitudinal targetsCattaneo, A. / Gennarelli, M. / Rudolf, U. / Breen, G. / Farmer, A. / Aitchison, K. J. / Anacker, C. / Zunsztain, P. A. / McGuffin, P. / Pariante, C. M. et al. | 2012
- S267
-
P.2.c.030 Volumetric changes in amygdala and hippocampus after three months of paroxetine treatment for major depressive disorderRuhe, H. G. / Miedema, E. / Booij, J. / Caan, M. W. / Veltman, D. J. / Schene, A. H. et al. | 2012
- S268
-
P.2.d.002 Preclinical effects of Lu AA21004, a novel multimodal antidepressantMork, A. / Pehrson, A. / Montezinho, L. C. / Karlsson, J. J. / Murphy, C. T. / Miller, S. / Fischer, C. W. / Liebenberg, N. / Wegener, G. / Sanchez, C. et al. | 2012
- S269
-
P.2.d.004 Effect of antidepressants and cyclo-oxygenase-2 inhibitor on cytokines and tryptophan metabolites after immune challenge in astrocytesWeiss, A. / Noll-Puchta, H. / Stettinger, W. / Schuetze, G. / Mueller, N. / Schwarz, M. / Myint, A. M. et al. | 2012
- S270
-
P.2.d.006 How does amitriptyline treatment affect coenzyme Q levels and oxidative stress in patients diagnosed with depressive disorder?Barquero, N. C. / Guillena, S. L. / Alcocer-Gomez, E. / Cordero, M. D. et al. | 2012
- S271
-
P.2.d.007 Presence of diurnal pattern of serum BDNF before partial sleep deprivation is associated with therapy response in major depressionGiese, M. / Beck, J. / Muheim, F. / Hatzinger, M. / Holsboer-Trachsler, E. / Eckert, A. et al. | 2012
- S272
-
P.2.d.009 A novel serotonin-preferred triple reuptake inhibitor, SKL10406, has competitive and tolerable anti-depression profileHan, S. / Ryu, E. J. / Lee, K. H. / Park, C. E. / Shin, Y. J. et al. | 2012
- S273
-
P.2.d.011 Sex differences in antidepressant response following adrenalectomy and stable corticosterone replacementKokras, N. / Dalla, C. / Sideris, A. / Papadopoulou-Daifoti, Z. et al. | 2012
- S274
-
P.2.d.012 Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatineMolteni, R. / Macchi, F. / Zecchillo, C. / Gabriel, C. / Mocaer, E. / Racagni, G. / Riva, M. A. et al. | 2012
- S275
-
P.2.d.015 microRNAs as novel antidepressant targets in refractory depression: converging effects of ketamine and electroconvulsive shock therapyOConnor, R. M. / Dinan, T. G. / Cryan, J. F. et al. | 2012
- S276
-
P.2.e.002 Depression, cortical excitability and sleep deprivation: a TMS/EEG studyCanali, P. / Casarotto, S. / Rosanova, M. / Pigorini, A. / Casali, A. G. / Mariotti, M. / Massimini, M. / Benedetti, F. et al. | 2012
- S278
-
P.2.e.005 Korean medication algorithm for bipolar disorderBahk, W. / Yoon, B. H. / Min, K. J. / Kim, W. / Joo, Y. H. / Seo, J. S. / Lee, J. G. / Shin, Y. C. / Jon, D. I. / Ahn, Y. M. et al. | 2012
- S279
-
P.2.e.007 Screening for bipolar disorder using a smartphoneBahk, W. / Hong, J. W. / Woo, Y. S. / Yoon, B. H. et al. | 2012
- S280
-
P.2.e.008 Implicit and explicit verbal memory performances of patients with bipolar disorder, their unaffected relatives and healthy controlsOzel-Kizil, E. T. / Baskak, B. / Cangoz, B. / Zivrali, E. / Cihan, B. / Ates, E. / Uran, P. et al. | 2012
- S281
-
P.2.e.010 Observational, multinational study of bipolar I and II disorders (WAVE-bd): comparison of clinical data between France and other countriesBellivier, F. / Medina, E. / Coulomb, S. / Lukasiewicz, M. et al. | 2012
- S282
-
P.2.e.012 Why do male bipolar patients not comply with treatment?Perez, P. V. / Garcia, S. R. / Resa, S. B. / Gonzalez-Ortega, I. / Ugarte, A. / Haidar, M. K. / Apaolaza, J. R. / Arrillaga, A. G. et al. | 2012
- S283
-
P.2.e.014 The symptom structure of bipolar acute episodes: the search for the mixing linkRibas, M. V. / Pacchiarotti, I. / Nivoli, A. M. / Mazzarini, L. / Koukopoulos, A. / Scott, J. / Murru, A. / Colom, F. / Vieta, E. et al. | 2012
- S284
-
P.2.e.015 Polarity index of drugs and psychotherapies in maintenance treatment of bipolar disorderPopovic, D. / Colom, F. / Valenti, M. / Vieta, E. et al. | 2012
- S285
-
P.2.e.017 DNA methylation is selectively altered in bipolar disorder and linked to DNA methyltransferases and histone deacetylases mRNAs levelsDAddario, C. / DellOsso, B. / Di Francesco, A. / Palazzo, M. C. / Benatti, B. / Galimberti, D. / Arosio, B. / Altamura, A. C. / Maccarrone, M. et al. | 2012
- S286
-
P.2.e.019 Remission of manic and depressive symptoms with asenapine in patients with mixed episodesAzorin, J. M. / Weiller, E. / Sapin, C. et al. | 2012
- S287
-
P.2.e.020 Prognostic value of affective symptomatology in first episodes of psychosisCulebra, N. C. / Arrasate, M. / Vega, P. / Vieta, E. / Gonzalez-Pinto, A. et al. | 2012
- S288
-
P.2.e.022 A study of reliability and validity of the Korean version of the quality of life in bipolar disorder questionnaireLee, S. / Lee, D. / Bahk, W. et al. | 2012
- S289
-
P.2.e.024 Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched controlsPalsson, E. / Figueras, C. / Johansson, A. / Ekman, C. J. / Hultman, B. / Landen, M. et al. | 2012
- S291
-
P.2.e.027 Interleukin-6 as a biomarker of the model of staging in bipolar disorderGrande, I. / Magalhaes, P. V. / Chendo, I. / Stertz, L. / Rosa, A. R. / Vieta, E. / Kapczinski, F. et al. | 2012
- S292
-
P.2.f.001 Effects of chronic lithium treatment on long-term potentiation and some behavioral tests in adult ratsSuer, C. / Kavraal, S. / Yousef, M. / Bitiktas, S. / Artis, A. S. / Dolu, N. et al. | 2012
- S293
-
P.2.f.003 Acute and repeated ketamine treatment leads to biphasic effects in the DRL72 test, a model for depression in ratsDe Haes, P. / Meynen, M. / Ver Donck, L. / Bouwknecht, A. et al. | 2012
- S294
-
P.2.f.005 A microarray study of lithium-treated mice and knockout mice with lithium-like behaviour reveals a common effect on mitochondrial functionToker, L. / Bersudsky, Y. / Belmaker, R. H. / Agam, G. et al. | 2012
- S296
-
P.2.g.002 The demographic and clinical characteristics of suicide attempters in KoreaLee, Y. / Kim, S. J. / Cho, I. H. / Lim, W. / Cho, S. J. et al. | 2012
- S297
-
P.2.g.004 Automated hippocampal subfields segmentation in late life depressionLee, C. / Lee, S. / Lim, H. et al. | 2012
- S299
-
P.2.g.007 Effects of induced thyroid hormone deficiency during differentiated thyroid cancer treatment in anxiety and depressionKim, J. S. / Suk, J. H. / Choi, W. J. et al. | 2012
- S300
-
P.2.g.009 One year follow-up of repetitive TMS efficacy in treatment-resistant major depression: report of two casesDurmaz, O. / Ates, M. A. / Gunay, H. / Basoglu, C. et al. | 2012
- S302
-
P.2.h.001 The effect of citalopram treatment on lipopolysaccharide-induced alterations in contextual learning and brain plasticity in the adult mouse hippocampusJaako, K. / Zharkovsky, A. et al. | 2012
- S303
-
P.3.a.001 Sex differences in early adolescent functioning among persons later hospitalised for schizophreniaUllman Zerem, V. / Levine, S. / Rabinowitz, J. et al. | 2012
- S304
-
P.3.a.002 Differences between late-onset schizophrenia and non-schizophrenic psychosis in a sample of elderly Egyptian patientsHussein, H. / El Shafei, A. / El Meguid, M. A. / El-Missiry, M. / Tamara, M. et al. | 2012
- S305
-
P.3.a.004 Artistic expression through an adherence to treatment in schizophreniaGuillena, S. L. / Henche, E. G. / Casado, P. V. et al. | 2012
- S306
-
P.3.a.006 Preliminary results of a prospective follow-up study of first episode acute transient psychotic disorder in LatviaRusaka, M. / Rancans, E. et al. | 2012
- S308
-
P.3.a.009 Effects of the interaction between adducins and EAAT2 polymorphisms on cognition in schizophrenia: preliminary findingsBosia, M. / Zagato, L. / Spangaro, M. / Merlino, L. / Pirovano, A. / Bramanti, P. / Manunta, P. / Smeraldi, E. / Cavallaro, R. et al. | 2012
- S309
-
P.3.a.011 Dietary intake in subjects with early psychosis: is there a relationship with clinical subtype or antipsychotic treatment?Monseny, R. / Ortega, L. / Montalvo, I. / Sole, M. / Gutierrez-Zotes, A. / Franch, J. / Reynolds, R. M. / Labad, J. et al. | 2012
- S311
-
P.3.a.014 Exploring the effect of genetic variability of adducins on cognition in schizophreniaBosia, M. / Zagato, L. / Casamassima, N. / Merlino, L. / Lorenzi, C. / Spangaro, M. / Smeraldi, E. / Cavallaro, R. / Manunta, P. et al. | 2012
- S312
-
P.3.a.016 Cognitive profile in subjects with early psychoses established by the MATRICS Consensus Cognitive BatteryCreus, M. / Montalvo, I. / Gutierrez-Zotes, A. / Ortega, L. / Monseny, R. / Franch, J. / Labad, J. et al. | 2012
- S313
-
P.3.a.017 Do attitudes towards medication adherence in schizophrenia vary between stakeholders? A comparison of survey resultsHargarter, L. / Emsley, R. / Alptekin, K. / Canas, F. / Gorwood, P. / Naber, D. / Olivares, J. M. / Papageorgiou, G. / Jones, K. / Schreiner, A. et al. | 2012
- S314
-
P.3.a.019 Validation of an automated rule switching test of executive functionWesnes, K. / Wojciak, R. / Feaster, H. J. / Pinho, M. / Kreftex, D. / Gruener, D. / Brownstein, L. / Glass, S. / Hassman, H. et al. | 2012
- S315
-
P.3.b.002 A dual rat model of schizophrenia reveals deficiencies in the gene and protein expression at the medial prefrontal cortex and amygdalaGilabert-Juan, J. / Saez, A. R. / Carceller, H. / Belles, M. / Molto, M. D. / Nacher, J. et al. | 2012
- S317
-
P.3.c.002 Comparison of discontinuation rates of atypical antipsychotics in acute-phase hospitalized patientsBahk, W. / Woo, Y. S. / Hahn, C. / Jun, T. Y. / Kim, K. S. et al. | 2012
- S318
-
P.3.c.004 The follow-up of akathisia and parkinsonian symptoms during the treatment of schizophrenia with olanzapine: a naturalistic studyKrzystanek, M. / Krupka-Matuszczyk, I. et al. | 2012
- S319
-
P.3.c.006 Safety and efficacy of olanzapine long-acting injection for up to 6 years in patients with schizophrenia or schizoaffective disorderMcDonnell, D. P. / Detke, H. C. / Choukour, M. / Landry, J. et al. | 2012
- S320
-
P.3.c.007 Conventional antipsychotics versus atypical antipsychotics in elderly patients with psychiatric disordersArnaoudova, M. et al. | 2012
- S321
-
P.3.c.009 Use of paliperidone palmitate long-acting injection in dual diagnosis patientsDe Cates, A. / Sridharan, S. / Ndebele, F. / Kunar, S. et al. | 2012
- S323
-
P.3.c.012 Treatment of glossodynia (burning mouth syndrome) with quetiapineCho, D. / Jee, H. / Je, H. et al. | 2012
- S324
-
P.3.c.014 Longitudinal changes of metabolic syndrome in patients with schizophrenia and bipolar disorderLee, N. Y. / Kim, S. H. / Ahn, Y. M. / Kang, U. G. / Youn, T. / Chung, I. W. / Kim, Y. S. et al. | 2012
- S326
-
P.3.c.017 The effect of second generation antipsychotics on cognition in patients with early psychosisMontalvo, I. / Creus, M. / Gutierrez-Zotes, A. / Ortega, L. / Monseny, R. / Feliu, T. / Franch, J. / Labad, J. et al. | 2012
- S328
-
P.3.c.020 Obsessive-compulsive disorder and hypochondriasis in schizophrenic patients treated with clozapine vs other atypical antipsychoticsGrassi, G. / Pellegrini, M. / Poli, L. / Pallanti, S. et al. | 2012
- S329
-
P.3.c.022 Risperidone long-acting injection in clinical practice: effects on symptoms and quality of lifeSingh, M. et al. | 2012
- S330
-
P.3.c.024 ALKS 9070, a novel once monthly prodrug of aripiprazole, achieves therapeutic levels and is well-tolerated in adults with schizophreniaTurncliff, R. / Potocka, E. / Corey, L. / Lowy, A. / Marandi, M. / DeSomer, M. / Ehrich, E. et al. | 2012
- S332
-
P.3.c.027 The effect of antipsychotic drug treatment on serum levels of vascular endothelial growth factor (VEGF), sVEGFR-1, and sVEGFR-2 in schizophreniaKim, D. H. / Sohn, B. K. / Lee, S. K. / Moon, Y. S. et al. | 2012
- S333
-
P.3.c.029 Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam in the treatment of acute agitation in schizophreniaHwang, T. J. / Chen, Y. H. / Huang, L. C. / Huang, G. H. / Hwu, H. G. et al. | 2012
- S334
-
P.3.c.031 Investigation of the applicability of a cybernetic model to clozapine-induced obsessive compulsive symptomsShin, S. Y. / Kim, S. H. / Lee, N. Y. / Ahn, Y. M. / Kang, U. G. / Youn, T. / Chung, I. W. / Kim, Y. S. et al. | 2012
- S335
-
P.3.c.033 Long-acting injectable vs. oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image and cohort studiesKishimoto, T. / Nitta, M. / Borenstein, M. / Kane, J. M. / Correll, C. U. et al. | 2012
- S336
-
P.3.c.034 Polypharmacy in schizophrenia treatmentTsopelas, C. / Ntounas, P. / Konsta, A. / Rizos, E. / Pappas, D. / Chatzimanolis, P. / Dimitraka, M. / Touloumis, C. / Douzenis, A. et al. | 2012
- S337
-
P.3.c.036 Metformin against antihistamine-induced weight gainHaller, I. / Vasic, N. / Schonfeldt-Lecuona, C. / Brummer, D. / Connemann, B. et al. | 2012
- S338
-
P.3.c.038 Initial experience with the Ratings Quality Questionnaire: a new tool for evaluating quality of clinical trials ratingsDaniel, D. / Kott, A. et al. | 2012
- S339
-
P.3.c.040 Effect of lurasidone on weight and metabolic parameters: a comprehensive analysis of short- and long-term trials in schizophreniaPikalov, A. / Cucchiaro, J. / Ogasa, M. / Silva, R. / Hsu, J. / Xu, J. / Loebel, A. et al. | 2012
- S340
-
P.3.c.041 Relapse prevention in schizophrenia: 12 month treatment with lurasidone versus quetiapine extended release among responders to acute treatmentPikalov, A. / Loebel, A. / Cucchiaro, J. / Xu, J. / Sarma, K. / Kane, J. et al. | 2012
- S341
-
P.3.c.043 Resistance to antipsychotics is associated with higher cognitive impairment compared to non-resistant schizophreniaIasevoli, F. / Balletta, R. / Giordano, S. / Buonaguro, E. F. / Latte, G. / de Bartolomeis, A. et al. | 2012
- S343
-
P.3.c.046 Insight and schizophrenia: comparison of efficacy by different antipsychoticsMagnano, F. / Cannavo, D. / Bianchini, O. / Battaglia, E. / Virzi, A. / Aguglia, E. et al. | 2012
- S344
-
P.3.d.002 Association of RGS2 gene polymorphic loci with schizophrenia and the response to typical antipsychoticsGareeva, A. / Khusnutdinova, E. / Zakirov, D. et al. | 2012
- S345
-
P.3.d.003 Increased pre-synaptic striatal uptake of dopamine as a potential mechanism of antipsychotic failureAmato, D. / Canneva, F. / Rauh, M. / Kornhuber, J. / von Horsten, S. / Muller, C. P. et al. | 2012
- S346
-
P.3.d.005 Why discordant findings are found in serotonin 5-HT2A receptor density in frontal cortex of subjects with schizophreniaMeana, J. J. / Muguruza, C. / Moreno, J. L. / Umali, A. / Callado, L. F. / Gonzalez-Maeso, J. et al. | 2012
- S347
-
P.3.d.007 Effect of chronic haloperidol treatment on the rat anterior cingulate cortex: linking neuroimaging findings with neuropathologyVernon, A. C. / Chege, W. / Crum, W. R. / Natesan, S. / Modo, M. / Cooper, J. D. / Williams, S. C. / Kapur, S. et al. | 2012
- S348
-
P.3.d.008 Glycogen synthase kinase (GSK)-3b signalling pathway in the rodent prefrontal cortex: a role in schizophrenia?Koros, E. / Rosenbrock, H. / Dorner-Ciossek, C. et al. | 2012
- S349
-
P.3.d.010 Effects of chronic exposure of cariprazine on dopamine receptor subtypesTarazi, F. / Choi, Y. K. / Adham, N. / Kiss, B. / Gyertyan, I. et al. | 2012
- S350
-
P.3.e.002 Metformin for weight loss in schizophrenia patients taking atypical antipsychoticsCho, D. / Je, H. / Park, S. et al. | 2012
- S351
-
P.3.e.003 Involuntary admission of first-episode psychotic patients and evolution up to 8 years of follow upBarbeito, S. / Vega, P. / de Azua, S. R. / Cengotitabengoa, M. M. / Garcia, B. / Gutierrez, M. / Pinto, A. G. et al. | 2012
- S352
-
P.3.e.005 Dietary habits, physical activity and metabolic profile in early psychosis: relation to perceived stress and psychopathologyOrtega, L. / Monseny, R. / Montalvo, I. / Manzanares, N. / Lopez, X. / Franch, J. / Reynolds, R. / Gutierrez-Zotes, A. / Labad, J. et al. | 2012
- S353
-
P.3.e.007 Substance use and pharmaceutical choices for patients who are involuntarily hospitalised in the Psychiatric Hospital of AthensTsopelas, C. / Ntounas, P. / Konsta, A. / Rizos, E. / Pappas, D. / Chatzimanolis, P. / Dimitraka, M. / Touloumis, C. / Douzenis, A. et al. | 2012
- S355
-
P.3.f.001 Effect of different antipsychotics on cytokines and tryptophan metabolites after different immune challenges in astrocytes cultureLopez, Y. P. / Weiss, A. / Noll-Puchta, H. / Stettinger, W. / Schuetze, G. / Mueller, N. / Schwarz, M. / Myint, A. M. et al. | 2012
- S356
-
P.3.f.003 Life stress is associated with excess calorie intake and sugar consumption in subjects with early psychosisManzanares, N. / Monseny, R. / Ortega, L. / Moreno, I. / Montalvo, I. / Gutierrez-Zotes, A. / Franch, J. / Reynolds, R. / Labad, J. et al. | 2012
- S358
-
P.4.a.003 Prevention of relapse in adult patients with generalised anxiety disorder after response to the multimodal psychotropic agent Lu AA21004Baldwin, D. S. / Loft, H. / Florea, I. et al. | 2012
- S359
-
P.4.a.005 Generalised anxiety disorder and panic disorder: a study focused on subthreshold symptoms and disabilityDellOsso, B. / Camuri, G. / Lietti, L. / Oldani, L. / Dobrea, C. / Benatti, B. / Arici, C. / Altamura, A. C. et al. | 2012
- S361
-
P.4.a.008 Active ingredients and mediators of cognitive behavioural therapy for panic disorder with agoraphobia: results from a randomized controlled trialGloster, A. / Klotsche, J. / Hofler, M. / Einsle, F. / Wittchen, H. U. et al. | 2012
- S362
-
P.4.a.010 Adult attention deficit hyperactivity disorder and anxiety disorder comorbidity: prevalence in a clinical sampleVan Ameringen, M. / Simpson, W. / Patterson, B. et al. | 2012
- S363
-
P.4.a.011 Post-traumatic stress disorder and medical cannabis use: a naturalistic observational studyReznik, I. et al. | 2012
- S364
-
P.4.a.013 Individual dental symptoms in burning mouth syndrome may be associated differentially with depression or anxietyDavies, S. J. / Underhill, H. C. / Scully, C. / Saeed, A. / Christmas, D. M. / Bolea-Alamanac, B. M. / Potokar, J. P. / Prime, S. S. et al. | 2012
- S366
-
P.4.a.016 What happens in the brain after successful vs. non-successful CBT treatment? A multicenter fMRI study on panic disorder with agoraphobiaLueken, U. / Straube, B. / Maslowski, N. / Wittchen, H. U. / Strohle, A. / Wittmann, A. / Pfleiderer, B. / Konrad, C. / Uhlmann, C. / Kircher, T. et al. | 2012
- S368
-
P.4.b.003 Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis and treatment outcome of panic disorderKim, W. / Woo, J. M. et al. | 2012
- S369
-
P.4.b.005 Activation of 5-HT1A receptors in the prelimbic cortex changes anxiety-related, but not panic-related, defensive responsesYamashita, P. S. / Zangrossi, H. et al. | 2012
- S371
-
P.4.c.001 Towards rational use of benzodiazepines in posttraumatic stress disorderSteenen, S. A. / van Westrhenen, R. / Mouthaan, J. / Gersons, B. P. / Olff, M. et al. | 2012
- S372
-
P.4.e.001 Screening for anxiety disorders in patients with coronary artery disease using self-rating scalesBunevicius, A. / Staniute, M. / Brozaitiene, J. / Bunevicius, R. et al. | 2012
- S374
-
P.4.e.004 The frequency of anxiety disorders in parents of children with attention deficit hyperactivity disorderKaramustafalioglu, K. / Sertcelik, S. / Bakim, B. / Abali, O. / Ozer, O. A. / Celik, S. et al. | 2012
- S376
-
P.4.e.007 Internet screening for anxiety disorders and effects on treatment-seeking three months laterVan Ameringen, M. / Simpson, W. / Patterson, B. et al. | 2012
- S378
-
P.4.f.001 The panicolytic-like effect of intra-dorsal periaqueductal grey matter injection of morphine in the elevated T-mazeBiesdorf, C. / Roncon, C. M. / Zangrossi, H. / Graeff, F. G. / Audi, E. A. et al. | 2012
- S379
-
P.4.f.003 Recent life stress in pregnant immigrant women and its association with HPA axis activityPeer, M. / Soares, C. N. / Levitan, R. / Streiner, D. / Steiner, M. et al. | 2012
- S380
-
P.4.f.005 Paroxysmal conditions in the structure of neurotic disorders and peculiarities of their correctionMaruta, N. / Kolyadko, S. et al. | 2012
- S382
-
P.5.a.003 Quality of life in mild cognitive impairment and mild Alzheimers diseaseShin, I. S. / Kim, J. M. / Kim, S. W. / Yoon, J. S. et al. | 2012
- S383
-
P.5.b.002 Comparative study of metrifonate and galantamine on active avoidance test and locomotor activity in rats with diazepam-induced amnesiaDimitrova, D. / Getova, D. et al. | 2012
- S385
-
P.5.c.002 Non-fatal and fatal liver failure associated with valproic acidSchonfeldt-Lecuona, C. / Connemann, B. / Gahr, M. / Keller, F. / Hiemke, C. / Freudenmann, R. W. et al. | 2012
- S386
-
P.5.e.001 Delirium of elderly patients in the emergency roomWoo, J. / Lee, J. / Park, S. Y. et al. | 2012
- S388
-
P.5.e.004 Treatment of Alzheimers disease: which effects on caregivers do we find?Riedel, O. / Wittchen, H. U. et al. | 2012
- S390
-
P.6.a.003 Influence of alcohol use on suicide lethality among suicide attemptersMin, S. / Park, S. / Kim, M. / Kim, H. / Jang, Y. et al. | 2012
- S391
-
P.6.a.006 A new original anticonvulsant decreases alcohol motivation and alters progesterone level in plasma of alcoholic patientsShushpanova, T. et al. | 2012
- S393
-
P.6.a.009 MTHFR polymorphisms and serum homocysteine levels in Korean patients with alcohol dependenceLee, B. H. / Lee, J. S. et al. | 2012
- S394
-
P.6.b.001 The acute effects of ethanol and acetaldehyde on physiological responses after ethanol ingestion in young healthy menBae, K. Y. / Kim, S. W. / Yoon, J. S. et al. | 2012
- S395
-
P.6.b.003 Liquids with negative redox potential reduce alcohol consumption and excessive motor activity in alcohol-dependent ratsSabitova, E. et al. | 2012
- S397
-
P.6.b.006 mGluR5 receptors on neurons expressing D1 dopamine receptors control escalation of alcohol drinking after abstinenceSikora, M. / Parkitna, J. R. / Golda, S. / Przewlocki, R. et al. | 2012
- S398
-
P.6.c.001 Legal and illegal substance consumption among Austrian studentsZachbauer, C. / Matznetter, A. / Koechl, B. / Metz, V. / Fischer, G. et al. | 2012
- S399
-
P.6.c.002 Naltrexone for opioid dependence: oral, implantable, and injectableKrupitsky, E. / Zvartau, E. / Blokhina, E. / Verbitskaya, E. / Woody, G. et al. | 2012
- S400
-
P.6.c.004 Effects of para-methoxyamphetamine (PMA) on anxiety in mice tested in the elevated plus mazeMuela, A. T. / Martin-Lopez, M. / Cavas, M. / Antunez, J. M. / Navarro, J. F. et al. | 2012
- S401
-
P.6.c.006 Association between the tyrosine hydroxylase gene and patients with methamphetamine dependenceOkahisa, Y. / Kishimoto, M. / Sakamoto, S. / Mizuki, Y. / Takaki, M. / Kodama, M. / Ujike, H. / Uchitomi, Y. et al. | 2012
- S402
-
P.6.c.008 Neural responses to rewards and punishments in patients with opiate dependence on methadone treatment: fNEMO studyGradin, V. / Gray, S. / MacFarlane, J. / Waiter, G. / Balfour, D. / Matthews, K. / Baldacchino, A. / Steele, D. et al. | 2012
- S403
-
P.6.c.010 Differences in cannabinoid-induced changes in cognitive performance in light stimulant and cannabis users versus heavy cannabis usersLevy-Cooperman, N. / Harrison, S. J. / Chen, N. L. / Chakraborty, B. et al. | 2012
- S405
-
P.6.d.001 The effects of MDMA pre-treatment on behavioural responses to mephedrone in the ratShortall, S. E. / Garner, R. / Worth, P. / Green, A. R. / Fone, K. C. / King, M. V. et al. | 2012
- S406
-
P.6.d.003 Ethological evaluation of the effects of MDEA, a recreational drug similar to MDMA, on anxiety in the elevated maze in miceMuela, A. T. / Martin-Lopez, M. / Navarro, J. F. et al. | 2012
- S408
-
P.6.d.006 Induction, expression and environmental conditioning in cocaine-induced behavioural sensitisation: are they related?Berro, L. F. / Hollais, A. W. / de Jesus, P. F. / Aramini, T. C. / Mari-Kawamoto, E. / Saito, L. P. / Wuo-Silva, R. / Morgado, F. / Frussa-Filho, R. et al. | 2012
- S409
-
P.6.d.008 Adenosine receptors modulate cannabinoid-induced impulsive and motivational responses in ratsPandolfo, P. / de Carvalho, C. R. / Pires, V. A. / Takahashi, R. N. et al. | 2012
- S410
-
P.6.e.002 Addiction relation with dopamine 2 receptor (DRD2) Taq1a polymorphism in heroin addictsYilbas, B. / Akkisi Kumsar, N. / Dilbaz, N. et al. | 2012
- S411
-
P.6.e.004 Smoking, nicotine dependence and anxiety in medical studentsVasylyeva, A. / Tabachnikov, S. / Ritkis, I. / Gurkova, A. et al. | 2012
- S412
-
P.6.f.001 Brizantin, a novel anti-nicotine agent, efficacy in the passive cigarette smoking modelZhavbert, E. / Dugina, J. / Vorobeva, T. / Kheyfets, I. / Guryanova, N. / Epstein, O. et al. | 2012
- S414
-
P.7.a.002 Treatment of psychiatric disorders in patients with tuberous sclerosis complexJovic, N. / Knezevic-Pogancev, M. / Ignjatovic, P. et al. | 2012
- S415
-
P.7.a.004 Obesity is associated with non-response to prolonged-release methylphenidate treatment in ADHDYook, K. H. / Kim, Y. W. / Suh, H. S. et al. | 2012
- S416
-
P.7.a.005 Relationship of olfactory functions and psychopathology in patients with autism spectrum disordersDudova, I. / Hrdlicka, M. et al. | 2012
- S417
-
P.7.a.007 Violence in an adolescent psychiatric inpatient unit: a behavioural management planShadili, G. / Brocco, C. / De Vieille, I. / Piot, M. A. / Lavergne, P. et al. | 2012
- S418
-
P.7.a.009 Predictors of diagnosis of nonaffective acute remitting psychosis in patients with early-onset first episodes of psychosisPina-Camacho, L. / Parellada, M. / Garcia-Prieto, J. / Castro-Fornieles, J. / Gonzalez-Pinto, A. / Graell, M. / Otero, S. / Moreno, D. / Arango, C. et al. | 2012
- S419
-
P.7.a.010 Dopaminergic crossroads: clinical implications in ADHD and restless leg syndromNeu, D. / Hardy De Buisseret, F. X. / Oswald, P. / Verbanck, P. et al. | 2012
- S420
-
P.7.a.012 Effects of OROS methylphenidate (OROS MPH) treatment in children and adolescents with ADHD, mental retardation and epilepsyKesic, A. / Lakic, A. / Dronjak, D. / Stupar, D. et al. | 2012
- S421
-
P.7.a.014 Methylphenidate effects on social functioning in children with ADHDCarucci, S. / Anchisi, L. / Ambu, G. / Melis, G. L. / Lecca, L. / Zuddas, A. et al. | 2012
- S423
-
P.7.b.002 Age-specific cumulative incidence risk for mental disorders as a function of familial liabilityBeesdo-Baum, K. / Low, N. C. / Knappe, S. / Behrendt, S. / Hofler, M. / Lieb, R. / Wittchen, H. U. et al. | 2012
- S425
-
P.7.b.005 Decreased serum levels of brain derived neurotrophic factor in adults with ADHDRamos-Quiroga, J. / Margarida Corominas, M. C. / Marta Ribases, M. R. / Cristina Sanchez-Mora, C. S. / Valero, S. V. / Rosa Bosch, R. B. et al. | 2012
- S426
-
P.7.c.001 Treatment adherence and parents characteristics in children with attention deficit hyperactivity disorderLee, S. / Seo, H. / Lim, H. / Jeong, J. / Hong, S. / Han, J. / Kim, J. et al. | 2012
- S427
-
P.7.c.003 Maintenance of response after open-label treatment with atomoxetine in adults with attention-deficit/hyperactivity disorderUpadhyaya, H. / Ramos-Quiroga, J. A. / Williams, D. / Tanaka, Y. / Lane, J. R. / Escobar, R. / Trzepacz, P. / Camporeale, A. / Allen, A. J. et al. | 2012
- S428
-
P.7.c.004 Tc-99m TRODAT brain SPECT changes in adolescents with attention deficit hyperactivity disorder after 2 months of methylphenidate therapyOzek, H. / Akay, A. / Kaya Capa, G. / Baykara, B. / Demir, Y. / Alsen, S. / Eren Sencan, M. / Emiroglu Inal, N. / Ertay, T. / Ozturk, Y. et al. | 2012
- S429
-
P.7.c.006 Changes in blood pressure and heart rate associated with atomoxetine treatment in attention-deficit/hyperactivity disorderCamporeale, A. / Beasley, C. / Tanaka, Y. / DSouza, D. / Upadhyaya, H. et al. | 2012
- S431
-
P.7.c.009 Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD: randomised withdrawal designCoghill, D. / Banaschewski, T. / Lecendreux, M. / Johnson, M. / Zuddas, A. / Anderson, C. / Civil, R. / Lyne, A. / Gasior, M. / Squires, L. et al. | 2012
- S432
-
P.7.d.002 The relationship between sleep duration and inflammatory markers in Korean adolescentsLee, Y. / Kim, S. / Cho, I. / Lim, W. et al. | 2012
- S433
-
P.7.d.003 Suicidal behaviour and internet use in adolescent depressionJon, D. I. / Choi, H. / Hong, H. J. / Jung, M. H. / Hong, N. / Kim, J. J. / Song, J. E. / Yook, K. H. et al. | 2012
- S434
-
P.7.d.005 Discriminative ability of a health-related quality of life questionnaire among referred adolescentsStevanovic, D. et al. | 2012
- S436
-
P.7.e.003 mGluR5 antagonist AFQ056/Mavoglurant in Fragile X Syndrome: baseline disease severity data in adults and adolescentsMatthisson, M. / Angelov, A. / Jaecklin, T. / Koumaras, B. / Collober, C. / Hossain, F. N. / Lustig, J. / Lee, J. / Graf, A. / von Raison, F. et al. | 2012
- S437
-
P.8.a.002 Reviewing and constructing clinical trials database for psychotropic drugs in KoreaLee, S. M. / Paik, J. W. / Song, J. Y. / Choi, Y. C. / Kang, S. H. / Park, J. I. et al. | 2012
- S438
-
P.8.a.003 Relationships between symptoms of Hwa-byung, distress and life problems in Korean female patients at a university cancer centerChoi, H. Y. / Lee, Y. J. / Bhan, Y. W. / Kim, S. C. / Ju, W. / Moon, B. I. / Paik, N. S. / Lim, W. J. et al. | 2012
- S439
-
P.8.b.001 Interaction of acetylcholinesterase reactivators with albuminZemek, F. / Sepsova, V. / Drtinova, L. / Korabecny, J. / Pohanka, M. / Zdarova Karasova, J. / Kuca, K. et al. | 2012
- S441
-
C.01.03 Outstanding needs in depression and how multimodal antidepressants may solve themBlier, P. et al. | 2012
- S443
-
C.03.02 Long-term management: how can long-acting injectables benefit patients with schizophrenia?Fleischhacker, W. et al. | 2012
- S444
-
C.04.02 What are the next steps? Combating inadequate response in MDDThase, M. et al. | 2012
- S446
-
C.06.02 Can our patients do better? The relationship between motivational deficits and functional outcomesFoussias, G. / Mann, S. / Zakzanis, K. K. / van Reekum, R. / Agid, O. / Remington, G. et al. | 2012
- S447
-
C.08.03 Achieving effective symptom control and remission in bipolar I disorderMcIntyre, R. et al. | 2012
- S448
-
C.10.03 Where do we go from here? Pharmacotherapy of mood disordersYoung, A. H. et al. | 2012
- S449
-
C.12.01 The need for expanding the treatment continuum in the treatment of alcohol dependencevan den Brink, W. et al. | 2012
- S450
-
C.13.01 The effect of antipsychotic medication on brain structure in schizophreniaFrangou, S. et al. | 2012
- S476
-
Circadian dimension and severity of depressionCourtet, P. / Olié / E. et al. | 2012
- S482
-
Synergistic mechanisms involved in the antidepressant effects of agomelatineTardito, D. / Molteni, R. / Popoli, M. / Racagni, G. et al. | 2012
- S487
-
Neural correlates of emotion processing: From emotional to social brainFossati, P. et al. | 2012
- S492
-
Onset, time course and trajectories of improvement with antidepressantsLam, R. W. et al. | 2012
- S499
-
The relation between mood, cognition and psychosocial functioning in psychiatric disordersIosifescu, D. V. et al. | 2012
- S505
-
Anhedonia and major depression: The role of agomelatineDi Giannantonio, M. / Martinotti, G. et al. | 2012
-
Editorial Board| 2012
-
P.2.b.006 Is the effect of imipramine in the forced swimming test mediated by a positive bias in the perception of response efficacy?Galistu, A. / DAquila, P. S. et al. | 2012
-
P.2.b.011 Depression-like symptoms and neurodegeneration under zinc-deficient conditionsMlyniec, K. / Budziszewska, B. / Reczynski, W. / Nowak, G. et al. | 2012
-
P.3.b.001 Cannabis use and psychotic experiences in UK teenagers - a longitudinal studyGage, S. / Hickman, M. / Heron, J. / Munafo, M. / Zammit, S. et al. | 2012
-
P.3.c.018 A placebo-controlled study of efficacy/safety of aripiprazole intramuscular depot for long-term maintenance treatment of schizophreniaSanchez, R. / Perry, P. / Jin, N. / Johnson, B. / Forbes, R. A. / McQuade, R. D. / Carson, W. H. / Fleischhacker, W. / Kane, J. M. et al. | 2012
-
P.6.a.005 Low-dose topiramate in alcohol dependence: a randomized, double-blind, placebo-controlled trialHatzigiakoumis, D. S. / Martinotti, G. / De Vita, O. / Di Nicola, M. / Gualtieri, I. / Tedeschi, D. / Guglielmo, R. / Quatrale, M. / Pozzi, G. / Janiri, L. et al. | 2012
-
P.6.b.002 Compulsive-impulsive alcohol consumption in serotonin deficient vesicular monoamine transporter 2 (Vmat2) knockout miceWeber, T. / Bilbao, A. / Berger, S. / Giros, B. / Spanagel, R. / Bartsch, D. et al. | 2012
-
C.01.02 The symptom of depression that nobody understandsLenze, E. et al. | 2012
-
S.04.02 Recruitment of the mTOR complex 1 by 5-HT6 receptors: potential role in the cognitive deficits of schizophreniaMeffre, J. / Mannoury la Cour, C. / Watson, D. / Loiseau, F. / Fone, K. / Millan, M. J. / Bockaert, J. / Marin, P. et al. | 2012
-
S.13.04 Immunotherapy in amyotrophic lateral sclerosisJulien, J. P. / Patel, P. / Kriz, J. / Gravel, C. et al. | 2012
-
S.23.02 The amygdala across anxiety disordersCardoner, N. / Menchon, J. M. / Soriano-Mas, C. et al. | 2012
-
S.26.03 Metadoxine: a novel non-stimulant extended-release drug for treating ADHDManor, I. / Ben-Hayun, R. / Aharon, J. / Salomy, D. / Weizman, A. / Danieli, Y. / Megiddo, D. / Newcorn, J. / Biederman, J. / Adler, L. A. et al. | 2012
-
P.1.a.009 Variation in the BDNF gene impacts on social stress-sensitivity: replication and extension of a gene-environment interaction findingvan Winkel, M. / Wichers, M. / Peeters, F. / Myin-Germeys, I. et al. | 2012
-
P.1.c.024 Prevention and reversal of ketamine-induced behavioural alterations by minocycline administration in miceCarvalho, A. F. / Monte, A. S. / Cordeiro, R. C. / Dos Santos, J. V. / Borella, V. C. / Oliveira, G. V. / Araujo, F. Y. / Oliveira, T. Q. / Escudeiro, S. S. / Macedo, D. S. et al. | 2012
-
P.1.g.008 Effect of resveratrol on BDNF in a chronic unpredictable mild stress model: an immunohistochemical studyYazir, Y. / Gocmez, S. / Utkan, T. / Kurnaz, S. / Gacar, N. / Aricioglu, F. et al. | 2012
-
Contents| 2012
-
P.1.027 Do antipsychotic drugs influence IL-4 and IL-6 serum levels in patients with schizophrenia?Borovcanin, M. / Dejanovic, S. D. / Radosavljevic, G. / Jovanovic, I. / Stefanovic, V. / Nenadovic, M. / Arsenijevic, N. et al. | 2012
-
P.1.025 Restoration of oscillatory changes in the genetic NMDA receptor hypofunction mutant PV-Cre/NR1f/fWang, X. / Darokhan, Z. / Carlen, M. et al. | 2012
-
P.1.029 Multimodal neuroimaging with PET and MRI to investigate the relation between serotonergic neurotransmission and regional brain volumesKraus, C. / Savli, M. / Hahn, A. / Hoflich, A. / Baldinger, P. / Wadsak, W. / Windischberger, C. / Mitterhauser, C. / Kasper, S. / Lanzenberger, R. et al. | 2012
-
P.2.005 The role of adolescent social behaviour in the development of impulse control in ratsBaarendse, P. / Vanderschuren, L. J. et al. | 2012
-
P.3.005 Tardive dyskinesia and polymorphisms of the phosphatidylinositol-4-phosphate 5-kinase IIa gene in Russian schizophrenic patientsGavrilova, V. A. / Fedorenko, O. Y. / Rudikov, E. V. / Boyarko, E. G. / Semke, A. V. / Sorokina, V. A. / Govorin, N. V. / Ivanova, S. A. et al. | 2012
-
ECNP Calendar of Events| 2012
-
S.01.01 Neural mechanisms of pathological gambling: fMRI studies of the motivational and impulse control systemGoudriaan, A. E. / van Holst, R. J. / Veltman, D. J. / de Ruiter, M. B. / Oosterlaan, J. / van den Brink, W. et al. | 2012
-
S.02.02 Bipolar disorder and borderline personality disorderVieta, E. et al. | 2012
-
S.09.03 Combining cognitive enhancers with cognitive training - lessons from neurobiology and implications for clinical studiesKapur, S. / Gilleen, J. / Panayiota, M. / Reichenberg, A. et al. | 2012
-
S.13.01 Immunotherapy in Alzheimers disease: is Ab the right target?Boche, D. et al. | 2012
-
S.15.01 Inhibitory circuitry of the mesolimbic systemTan, K. / Luscher, C. et al. | 2012
-
S.18.01 The translational neuropharmacology of ketamineDeakin, J. F. / Hodkinson, D. / Gigg, J. / Williams, S. R. et al. | 2012
-
S.20.02 Neural correlates of cognitive flexibility in monkeysSnyder, L. H. / Stoet, G. et al. | 2012
-
S.21.01 Deep brain stimulation for OCD and Tourette syndromeCavanna, A. et al. | 2012
-
S.22.03 Positive affect and recovery from depressionWichers, M. / Menne-Lothmann, C. / Vercauteren, P. / Peeters, F. / Van Os, J. et al. | 2012
-
S.25.02 Results from clinical trials with monoclonal antibodies in Alzheimers diseasePrins, N. D. et al. | 2012
-
S.26.04 Comorbidity between ADHD and bipolar disorderYazgan, Y. et al. | 2012
-
P.1.b.001 Heart rate variability spectral analysis in patients with panic disorder compared with healthy controlsDiveky, T. / Kamaradova, D. / Prasko, J. / Grambal, A. et al. | 2012
-
P.1.b.006 Cannabinoid CB2 receptor gene expression alterations in the dorsolateral prefrontal cortex and amygdala of suicide victimsGarcia-Gutierrez, M. S. / Navarrete, F. / Giner, S. / Manzanares, J. et al. | 2012
-
P.1.c.007 Is neuropathic pain alleviation by antidepressants mediated through anti-neuroinflammatory properties?Bourgoin, S. / Michot, B. / Viguier, F. / Weber, M. / Figueiredo, A. C. / Jeanson, T. / Hamon, M. et al. | 2012
-
P.1.g.012 Eye movements during an image comparison task can be used to characterise the cognitive deficits associated with psychiatric pathologiesJaafari, N. / Lafay, N. L. / Chopin, N. / Rigalleau, F. / Vibert, N. et al. | 2012
-
P.1.g.013 Adaptation and validation of a source monitoring behavioural task to the fMRI environmentBraha-Zeitoun, S. / Rodriguez, E. / Moulier, V. / Peuchot, M. / Sidhoumi, D. / Januel, D. et al. | 2012
-
P.1.i.006 Assessment of olfactory impairment in non-demented rural community-dwelling older adults in PolandPalys, W. / Suwalska, A. / Jeszka, J. / Rybakowski, J. K. et al. | 2012
-
P.1.i.005 Decreased serum brain-derived neurotrophic factor (BDNF) levels in sleep-disturbed subjectsEckert, A. / Giese, M. / Unternahrer, E. / Huttig, H. / Brand, S. / Calabrese, P. / Holsboer-Trachsler, E. et al. | 2012
-
ECNP_Vienna_ad| 2012
-
P.2.c.017 Cardiological changes during antidepressant treatment with SSRIs - a drug surveillance report of German-speaking countriesSpindelegger, C. / Papageorgiou, K. / Agelink, M. W. / Greil, W. / Bleich, S. / Ruther, E. / Grohmann, R. / Toto, S. / Konstantinidis, A. / Kasper, S. et al. | 2012
-
P.2.c.024 PharmacoMRI and cognitive effects of the potential antidepressant AZD6765 compared with ketamine in untreated major depressive disorderDeakin, J. / Williams, S. / Downey, D. / McKie, S. / Goodwin, G. / Harmer, C. / Dourish, C. / Dawson, G. / McCarthy, D. / Smith, M. et al. | 2012